Publikationen

• Publikationen 2018
• Publikationen 2017
• Publikationen 2016
• Publikationen 2015
• Publikationen 2014
• Publikationen 2013
• Publikationen 2012
• Publikationen 2011
• Publikationen 2010
• Publikationen 2009
• Publikationen 2008
• Publikationen 2007
• Publikationen 2006
• Publikationen 2005

2018

Role of p16(INK4A) in detection of human papillomavirus DNA and stratification of cancer-specific mortality on the basis of long term follow-up data of 34 patients with invasive penile cancer]
Aktuelle Urol. 2018; Bründl J, Neppl C, Hommer T, Otto W, Breyer J, Brookman-May S, Weber F, Burger M, May M, Eichelberg C

Management of penile cancerpatients: newaspects of a rare tumour entity.
Aktuelle Urol. 2018;49(3): 242-249; Roiner M, Maurer O, Lebentrau S, Gilfrich C, Schäfer C, Haberl C, Brookman-May SD, Burger M, May M, Hakenberg OW

Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study
BJU Int. 2018;121(1): 101-110; Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, FritscheHM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group , Bartsch G, Bolenz C, Brookman-May S, Buchner A, Durschnabel M, Ellinger J, Froehner M, Georgieva G, Gilfrich C, Gördük M, Grimm MO, Hadaschik B, Haferkamp A, Hartmann F, Herrmann E, Hertle L, Hohenfellner M, Janetschek G, Keck B, Kraischits N, Krausse A, Lusuardi L, Martini T, Michel MS, Moritz R, Müller SC, Novotny V, Pahernik S, Palisaar RJ, Ponholzer A, Roigas J, Schmid M, Schramek P, Seitz C, Sikic D, Stief CG, Syring I, Traumann M, Vallo S, Wagenlehner FM, Weidner W, Wirth MP, Wullich B

The World Health Organization1973classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer
BJU Int. 2018;122(6): 978-985; van de Putte EEF, Bosschieter J, van der Kwast TH, Bertz S, Denzinger S, Manach Q, Compérat EM, Boormans JL, Jewett MAS, Stoehr R, van Leenders GJLH, Nieuwenhuijzen JA, Zlotta AR, Hendricksen K, Rouprêt M, Otto W, Burger M, Hartmann A, van Rhijn BWG

Expression, localisation and potentialsignificance of aquaporins in benign and malignant human prostate tissue
BMC Urol. 2018;18(1): 75; Bründl J, Wallinger S, Breyer J, Weber F, Evert M, Georgopoulos NT, Rosenhammer B, Burger M, Otto W, Rubenwolf P

HighPDL1mRNAexpression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients
Cancer Immunol Immunother. 2018;67(3): 403-412; Breyer J, Wirtz RM, Otto W, Erben P, Worst TS, Stoehr R, Eckstein M, Denzinger S, Burger M, Hartmann A

HighCDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma
Clin Genitourin Cancer. 2018;16(4): 248-256.e2; Breyer J, Wirtz RM, Erben P, Worst TS, Stoehr R, Eckstein M, Bertz S, Sikic D, Denzinger S, Burger M, Hartmann A, Otto W, Bladder Cancer Research Initiative for Drug Targets Germany (BRIDGE) Consortium eV, Mannheim, Germany , Breyer J, Wirtz RM, Erben P, Worst TS, Stoehr R, Eckstein M, Sikic D, Burger M, Hartmann A, Otto W

Influence of Gender and Age on the Willingness to Reduce Nicotine Consumption-Results of a Survey in Urological Cancer Patients (KRAUT Study)
Clin Genitourin Cancer. 2018;16(6): e1181-e1187; Dombrowski M, May M, Spachmann PJ, Ganesh Kumar M, Fritsche HM, Brookman-May S, Maurer O, Burger M, Gilfrich C

T1High-gradeBladder Cancer: The Search for the Optimal Management Continues
Eur Urol. 2018;74(5): 609-610; Mostafid H, Palou J, Burger M, Babjuk M

EuropeanAssociation of UrologyGuidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
Eur Urol. 2018;73(1): 111-122; Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF

Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?
Eur Urol Focus. 2018;4(4): 525-528; Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid HA, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Zigeuner R, Capoun O, Cohen D, Dominguez-Escrig JL, Hernández V, Peyronnet B, Seisen T, Soukup V, European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer

Training, Research, and WorkingConditions for UrologyResidents in Germany: A Contemporary Survey
Eur Urol Focus. 2018;4(3): 455-460; Borgmann H, Arnold HK, Meyer CP, Bründl J, König J, Nestler T, Ruf C, Struck J, Salem J

Hexvixplus Chemo
Eur Urol Focus. 2018;4(4): 468-469; Burger M

Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016"
Eur Urol Focus. 2018; Compérat EM, Burger M, Gontero P, Mostafid AH, Palou J, Rouprêt M, van Rhijn BWG, Shariat SF, Sylvester RJ, Zigeuner R, Babjuk M

RiskStratificationTools and PrognosticModels in Non-muscle-invasiveBladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasiveBladder Cancer Guidelines Panel
Eur Urol Focus. 2018; Soukup V, Capoun O, Cohen D, Hernández V, Burger M, Compérat E, Gontero P, Lam T, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Yuan Y, Zigeuner R, Babjuk M

Effectiveness of Adjuvant ChemotherapyAfterRadicalCystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis
Eur Urol Focus. 2018;4(2): 252-259; Vetterlein MW, Seisen T, May M, Nuhn P, Gierth M, Mayr R, Fritsche HM, Burger M, Novotny V, Froehner M, Wirth MP, Protzel C, Hakenberg OW, Roghmann F, Palisaar RJ, Noldus J, Pycha A, Bastian PJ, Trinh QD, Xylinas E, Shariat SF, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A, PROMETRICS 2011 Study Group

Highproliferationrate and TNM-stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma
Hum Pathol. 2018; Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P, Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-Göppinger S, Höfler H, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Haferkamp A, Geppert CI, Stöhr C, Hartmann A, German Network Of Kidney Cancer

Long-termoutcomeaftergrafting with small intestinalsubmucosa and collagen fleece in patients with Peyronie's disease: a matched pair analysis
Int J Impot Res. 2018;Rosenhammer B, Sayedahmed K, Fritsche HM, Burger M, Kübler H, Hatzichristodoulou G

mRNA-Expression of KRT5 and KRT20DefinesDistinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants
Int J Mol Sci. 2018;19(11); Eckstein M, Wirtz RM, Gross-Weege M, Breyer J, Otto W, Stoehr R, Sikic D, Keck B, Eidt S, Burger M, Bolenz C, Nitschke K, Porubsky S, Hartmann A, Erben P

Infiltrativelamina propriainvasionpattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naive stage T1 high-grade urothelial bladder cancer
Int J Urol. 2018;25(5): 442-449; Otto W, van Rhijn BW, Breyer J, Bertz S, Eckstein M, Mayr R, Lausenmeyer EM, Denzinger S, Burger M, Hartmann A

What do patients with urothelialcancer know about the association of their tumor disease with smoking habits? Results of a German survey study
Investig Clin Urol. 2018;59(2): 91-97;
May M, Fritsche HM, Gilfrich C, Dombrowski M, Maurer O, Spachmann P, Kumar MG, Bjurlin M, Burger M, Brookman-May S

Sarcopenia as a comorbidity-independentpredictor of survival following radical cystectomy for bladder cancer
J Cachexia Sarcopenia Muscle. 2018;9(3): 505-513; Mayr R, Gierth M, Zeman F, Reiffen M, Seeger P, Wezel F, Pycha A, Comploj E, Bonatti M, Ritter M, van Rhijn BWG, Burger M, Bolenz C, Fritsche HM, Martini T

Codon72Polymorphism and Risk for Squamous CellCarcinoma of the Penis: A Caucasian Case-ControlStudy
J Cancer. 2018;9(22): 4234-4241; Stoehr R, Weisser R, Wendler O, Giedl J, Daifalla K, Gaisa NT, Richter G, Campean V, Burger M, Wullich B, Hartmann A

FOXM1predictsdisease progression in non-muscleinvasivebladder cancer
J Cancer Res Clin Oncol. 2018;144(9): 1701-1709; Rinaldetti S, Wirtz R, Worst TS, Hartmann A, Breyer J, Dyrskjot L, Erben P

ProspectiveEvaluation of PredictiveParameters for Urinary Tract Infection in Patients with Acute Renal Colic
J Emerg Med. 2018;55(3): 319-326; Rosenhammer B, Spachmann PJ, Burger M, Fritsche HM, Schnabel MJ

Diagnosis, Treatment, and Outcome of ArterioureteralFistula: The Urologist's Perspective
J Endourol. 2018;32(3): 245-251; Heers H, Netsch C, Wilhelm K, Secker A, Kurtz F, Spachmann P, Viniol S, Hofmann R, Hegele A

Improvedprediction of nephron-sparingsurgeryversusradical nephrectomy by the optimized R.E.N.A.L. (optR.E.N.A.L.) score in patients undergoing surgery for renal masses
Minerva Urol Nefrol. 2018; Sterzik A, Solyanik O, Eichelberg C, Jost M, Graser A, Lausenmeyer EM, Otto W, Waidelich R, Stief CG, Burger M, May M, Brookman-May SD

Differentiation-associatedurothelial cytochrome P450 oxidoreductase predicates the xenobiotic-metabolizing activity of "luminal" muscle-invasive bladder cancers
Mol Carcinog. 2018;57(5): 606-618;
Baker SC, Arlt VM, Indra R, Joel M, Stiborová M, Eardley I, Ahmad N, Otto W, Burger M, Rubenwolf P, Phillips DH, Southgate J

A multicenterroundrobintest of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy .
Oncotarget. 2018;9(19): 15001-15014; Eckstein M, Wirtz RM, Pfannstil C, Wach S, Stoehr R, Breyer J, Erlmeier F, Günes C, Nitschke K, Weichert W, Otto W, Keck B, Eidt S, Burger M, Taubert H, Wullich B, Bolenz C, Hartmann A, Erben P

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
Sci Rep. 2018;8(1): 14383; Worst TS, Weis CA, Stöhr R, Bertz S, Eckstein M, Otto W, Breyer J, Hartmann A, Bolenz C, Wirtz RM, Erben P

PrognosticValue of MolecularBreast CancerSubtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer
Transl Oncol. 2018;11(2): 467-476; Kriegmair MC, Wirtz RM, Worst TS, Breyer J, Ritter M, Keck B, Boehmer C, Otto W, Eckstein M, Weis CA, Hartmann A, Bolenz C, Erben P

Accordance of OnlineHealthInformation on Prostate Cancer with the European Association of Urology Guidelines
Urol Int. 2018;100(3): 288-293; Bruendl J, Rothbauer C, Ludwig B, Dotzler B, Wolff C, Reimann S, Borgmann H, Burger M, Breyer J

Influence of Body Mass Index on ClinicalOutcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study
Urol Int. 2018;101(1): 16-24; Gierth M, Zeman F, Denzinger S, Vetterlein MW, Fisch M, Bastian PJ, Syring I, Ellinger J, Müller SC, Herrmann E, Gilfrich C, May M, Pycha A, Wagenlehner FM, Vallo S, Bartsch G, Haferkamp A, Grimm MO, Roigas J, Protzel C, Hakenberg OW, Fritsche HM, Burger M, Aziz A, Mayr R

Holmium LaserEnucleation of the ProstateProvidesSimilar Incidental Prostate Cancer Detection Rates as Open Prostatectomy: A Matched Pair Analysis.
Urol Int. 2018;101(4): 382-386; Rosenhammer B, Lausenmeyer EM, Mayr R, Burger M, Eichelberg C

Metricsubstageaccording to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer
Urol Oncol. 2018;36(8): 361.e7-361.e13; Fransen van de Putte EE, Otto W, Hartmann A, Bertz S, Mayr R, Bründl J, Breyer J, Manach Q, Compérat EM, Boormans JL, Bosschieter J, Jewett MAS, Stoehr R, van Leenders GJLH, Nieuwenhuijzen JA, Zlotta AR, Hendricksen K, Rouprêt M, Burger M, van der Kwast TH, van Rhijn BWG

The prognosticeffect of salvagesurgery and radiotherapy in patients with recurrent primary urethral carcinoma
Urol Oncol. 2018;36(1): 10.e7-10.e14; Gakis G, Schubert T, Morgan TM, Daneshmand S, Keegan KA, Mischinger J, Clayman RH, Brisuda A, Ali-El-Dein B, Galland S, Gregg J, Balci M, Olugbade K, Rink M, Fritsche HM, Burger M, Babjuk M, Stenzl A, Thalmann GN, Kübler H, Efstathiou JA

Erratum to 'Predictivevalue of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy' [Urologic Oncology: Seminars and Original Investigations 36/12 (2018) 505-534
Urol Oncol. 2018; Martini T, Heinkele J, Mayr R, Weis CA, Wezel F, Wahby S, Eckstein M, Schnöller T, Breyer J, Wirtz R, Ritter M, Bolenz C, Erben P

Predictivevalue of lymphangiogenesis and proliferationmarkers on mRNAlevel in urothelial carcinoma of the bladder after radical cystectomy
Urol Oncol. 2018;36(12): 530.e19-530.e27; Martini T, Heinkele J, Mayr R, Weis CA, Wezel F, Wahby S, Eckstein M, Schnöller T, Breyer J, Wirtz R, Ritter M, Bolenz C, Erben P

p53-expression in patients with renal cell carcinomacorrelates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models
Urol Oncol. 2018;36(3): 94.e15-94.e21; Morshaeuser L, May M, Burger M, Otto W, Hutterer GC, Pichler M, Klatte T, Wild P, Buser L, Brookman-May S

Impact of surgeon's experience on outcome parameters following ureterorenoscopic stone removal
Urolithiasis. 2018; Wolff I, Lebentrau S, Miernik A, Ecke T, Gilfrich C, Hoschke B, Schostak M, May M, BUSTER study group , Baars A, Balsmeyer U, Burger M, de Boer MC, Danzer G, Enzmann T, Fahlenkamp D, Filter S, Fritsche HM, Hallmann S, Hebert J, Huber T, Lehsnau M, Müller PF, Peter J, Porsch M, Promnitz S, Rodat M, Schmidt W, Schoeneich F, Schoenthaler M, Weikert S, Werthemann P, Ziegler H

Imaging in individualizeduro-oncology
Urologe A. 2018;57(9): 1048-1057; Bründl J, Breyer J, Burger M

Molecularcharacterization of penile cancer: Literature review of new prognostic markers and potential therapeutic targets
Urologe A. 2018;57(4): 398-407; May M, Brookman-May SD, Ecke TH, Burger M

Interraterreliability and clinicalimpact of the Post-Ureteroscopic Lesion Scale (PULS) grading system for ureteral lesions after ureteroscopy: Results of the German prospective multicenter BUSTER project
Urologe A. 2018;57(2): 172-180; May M, Schönthaler M, Gilfrich C, Wolff I, Peter J, Miernik A, Fritsche HM, Burger M, Schostak M, Lebentrau S, BUSTER-Arbeitsgruppe , Baars A, Balsmeyer U, Burger M, de Boer MC, Danzer G, Ecke T, Enzmann T, Fahlenkamp D, Filter S, Fritsche HM, Gilfrich C, Hallmann S, Hebert J, Hoschke B, Huber T, Lebentrau S, Lehsnau M, May M, Miernik A, Mueller PF, Peter J, Porsch M, Promnitz S, Rodat M, Schmidt W, Schoeneich F, Schoenthaler M, Schostak M, Weikert S, Werthemann P, Wolff I, Ziegler H

Analysis of the prognosticrelevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder
Virchows Arch. 2018; Erben P, Sikic D, Wirtz RM, Martini T, Weis CA, Breyer J, Otto W, Keck B, Hartmann A, Bolenz C, BRIDGE Consortium e.V., Erben P, Sikic D, Wirtz RM, Martini T, Breyer J, Otto W, Keck B, Hartmann A, Bolenz C

Multicenterevaluation of guideline adherence for pelviclymph node dissection in patients undergoing open retropubic vs. laparoscopic or robot assisted radical prostatectomy according to the recent German S3 guideline on prostate cancer
World J Urol. 2018;36(6): 855-861; BorkowetzA, Bruendl J, Drerup M, Herrmann J, Isbarn H, Beyer B, GeSRU Academics Prostate Cancer Group

Wake-upcall for more doctor-patient communication and an increase in public information campaigns on the risk factor of smoking with regard to the development and prognosis of bladder cancer
World J Urol. 2018; Gilfrich C, Maurer O, Spachmann PJ, Dombrowski MK, Burger M, May M

Hospitalvolume in ureterorenoscopicstonetreatment: 99 operations per year could increase the chance of a better outcome-results of the German prospective multicentre BUSTER project
World J Urol. 2018; Lebentrau S, Enzmann T, Lehsnau M, Christoph F, Schostak M, May M, BUSTER study group , Baars A, Balsmeyer U, Burger M, de Boer MC, Danzer G, Ecke T, Enzmann T, Fahlenkamp D, Filter S, Fritsche HM, Gilfrich C, Hallmann S, Hebert J, Hoschke B, Huber T, Lebentrau S, Lehsnau M, May M, Miernik A, Müller PF, Peter J, Porsch M, Promnitz S, Rodat M, Schmidt W, Schoeneich F, Schoenthaler M, Schostak M, Weikert S, Werthemann P, Wolff I, Ziegler H

Sarcopeniapredicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer
World J Urol. 2018;36(8): 1201-1207; Mayr R, Fritsche HM, Zeman F, Reiffen M, Siebertz L, Niessen C, Pycha A, van Rhijn BWG, Burger M, Gierth M

HoLEPprovides a higherprostate cancer detection rate compared to bipolar TURP: a matched-pair analysis
World J Urol. 2018;36(12): 2035-2041; Rosenhammer B, Lausenmeyer EM, Mayr R, Burger M, Eichelberg C

2017

Clinical and pathological prognostic factors for the long-term survival of patients with pT1 renal cell carcinoma
Aktuelle Urol. 2017;48(3): 230-237; Breyer J, Otto W, Lausenmeyer EM, Denzinger S, Schwientek AK, Ochs L, Mayr R, Gierth M, Bründl J, Burger M, Evert M, Fritsche HM, Eichelberg C

Management of penile cancer patients: new aspects of a rare tumour entity
Aktuelle Urol. 2017; Roiner M, Maurer O, Lebentrau S, Gilfrich C, Schäfer C, Haberl C, Brookman-May SD, Burger M, May M, Hakenberg OW

Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study
BJU Int. 2017; Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A, PROMETRICS 2011 Study Group , Bartsch G, Bolenz C, Brookman-May S, Buchner A, Durschnabel M, Ellinger J, Froehner M, Georgieva G, Gilfrich C, Gördük M, Grimm MO, Hadaschik B, Haferkamp A, Hartmann F, Herrmann E, Hertle L, Hohenfellner M, Janetschek G, Keck B, Kraischits N, Krausse A, Lusuardi L, Martini T, Michel MS, Moritz R, Müller SC, Novotny V, Pahernik S, Palisaar RJ, Ponholzer A, Roigas J, Schmid M, Schramek P, Seitz C, Sikic D, Stief CG, Syring I, Traumann M, Vallo S, Wagenlehner FM, Weidner W, Wirth MP, Wullich B

Changes in intraocular pressure and optic nerve sheath diameter in patients undergoing robotic-assisted laparoscopic prostatectomy in steep 45° Trendelenburg position
BMC Anesthesiol. 2017;17(1): 40; Blecha S, Harth M, Schlachetzki F, Zeman F, Blecha C, Flora P, Burger M, Denzinger S, Graf BM, Helbig H, Pawlik MT

Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer
Bladder Cancer. 2017;3(3): 173-180; Breyer J, Shalekenov S, Aziz A, van Rhijn BWG, Bründl J, Lausenmeyer E, Schäfer J, Denzinger S, Giedl C, Burger M, Hartmann A, Evert M, Otto W

Aquaporin 3 Expression Loss in Urothelial Carcinoma: Association with Tumor Invasion Depth, but not with Grading?
Bladder Cancer. 2017;3(1): 31-34; Breyer J, Otto W, Burger M, Hartmann A, Rubenwolf PC

High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients
Cancer Immunol Immunother. 2017; Breyer J, Wirtz RM, Otto W, Erben P, Worst TS, Stoehr R, Eckstein M, Denzinger S, Burger M, Hartmann A

The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians
Clin Genitourin Cancer. 2017;15(3): 356-362; Martini T, Gilfrich C, Mayr R, Burger M, Pycha A, Aziz A, Gierth M, Stief CG, Müller SC, Wagenlehner F, Roigas J, Hakenberg OW, Roghmann F, Nuhn P, Wirth M, Novotny V, Hadaschik B, Grimm MO, Schramek P, Haferkamp A, Colleselli D, Kloss B, Herrmann E, Fisch M, May M, Bolenz C

Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort
Clin Genitourin Cancer. 2017;15(5): e809-e817; Vetterlein MW, Meyer CP, Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, Keck B, Wullich B, Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian PJ, Gilfrich C, May M, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A, PROMETRICS 2011 study group , Bartsch G, Brookman-May S, Buchner A, Durschnabel M, Ellinger J, Froehner M, Georgieva G, Gördük M, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Hartmann F, Herrmann E, Hertle L, Hohenfellner M, Janetschek G, Kraischits N, Krausse A, Lusuardi L, Michel MS, Moritz R, Müller SC, Novotny V, Nuhn P, Pahernik S, Palisaar RJ, Ponholzer A, Protzel C, Roigas J, Schmid M, Schramek P, Seitz C, Sikic D, Stief CG, Syring I, Vallo S, Wagenlehner FM, Weidner W, Wirth MP

Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61
Eur Urol. 2017;71(6): e173-e174; Babjuk M, Burger M, Compérat E, Palou J, Rouprêt M, van Rhijn B, Shariat S, Sylvester R, Zigeuner R, Gontero P, Mostafid H

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Eur Urol. 2017;71(3): 447-461; Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M, van Rhijn BW, Shariat SF, Soukup V, Sylvester RJ, Zigeuner R

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
Eur Urol. 2017; Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF

Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
Eur Urol. 2017;72(5): 801-813; Soukup V, Čapoun O, Cohen D, Hernández V, Babjuk M, Burger M, Compérat E, Gontero P, Lam T, MacLennan S, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Sylvester R, Yuan Y, Zigeuner R

Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer
Eur Urol Focus. 2017; Dominguez-Escrig JL, Peyronnet B, Seisen T, Bruins HM, Yuan CY, Babjuk M, Böhle A, Burger M, Compérat EM, Gontero P, Lam T, MacLennan S, Mostafid H, Palou J, van Rhijn BWG, Sylvester RJ, Zigeuner R, Shariat SF, Rouprêt M

Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review
Eur Urol Focus. 2017; Peyronnet B, Seisen T, Dominguez-Escrig JL, Bruins HM, Yuan CY, Lam T, Maclennan S, N'dow J, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Mostafid H, van Rhijn BWG, Gontero P, Palou J, Shariat SF, Roupret M

Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship
Int Urol Nephrol. 2017;49(8): 1311-1318; Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner FM, Burger M, May M, MR2 study group , Beiser S, Bernhardt J, Bschleipfer T, Dirik Ö, Geiss J, Hauner K, Hoschke B, Karl T, Kestler A, Klotz T, Kuhl C, Lehsnau M, Macht A, Magistro G, Maurer O, Novotny A, Necknig U, Obermaier R, Promnitz S, Retz M, Scheu C, Scholz C, Stief CG, Truß M

Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database
Int Urol Nephrol. 2017;49(2): 247-254; May M, Protzel C, Vetterlein MW, Gierth M, Noldus J, Karl A, Grimm T, Wullich B, Grimm MO, Nuhn P, Bastian PJ, Roigas J, Hadaschik B, Gilfrich C, Burger M, Fisch M, Brookman-May S, Aziz A, Hakenberg OW, PROMETRICS 2011 Research Group , Bartsch G, Bolenz C, Buchner A, Chun FK, Durschnabel M, Ellinger J, Fritsche HM, Froehner M, Georgieva G, Gilfrich C, Gördük M, Haferkamp A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, Keck B, Kraischits N, Krausse A, Lusuardi L, Martini T, Mayr R, Moritz R, Müller SC, Novotny V, Pahernik S, Palisaar RJ, Ponholzer A, Pycha A, Rink M, Roghmann F, Schmid M, Schramek P, Seitz C, Shariat SF, Sikic D, Stief CG, Syring I, Vallo S, Wagenlehner FM, Wirth MP

WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach
Int Urol Nephrol. 2017;49(3): 431-437; Otto W, Breyer J, Herdegen S, Eder F, Bertz S, May M, Mayr R, Lausenmeyer EM, Denzinger S, van Rhijn BW, Burger M, Hartmann A

Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years
J Cancer. 2017;8(3): 323-331; Weyerer V, Schneckenpointner R, Filbeck T, Burger M, Hofstaedter F, Wild PJ, Fine SW, Humphrey PA, Dehner LP, Amin MB, Rüschoff J, Boltze C, Tannapfel A, Zwarthoff E, Lopez-Beltran A, Montironi R, Langner C, Stoehr R, Hartmann A, Giedl J

Prostate Cancer on the Web-Expedient Tool for Patients' Decision-Making?
J Cancer Educ. 2017;32(1): 135-140;  Borgmann H, Wölm JH, Vallo S, Mager R, Huber J, Breyer J, Salem J, Loeb S, Haferkamp A, Tsaur I

Bladder cancer.
Nat Rev Dis Primers. 2017;3: 17022; Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y

Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies
Oncotarget. 2017;8(40): 67684-67695; Breyer J, Wirtz RM, Otto W, Laible M, Schlombs K, Erben P, Kriegmair MC, Stoehr R, Eidt S, Denzinger S, Burger M, Hartmann A

FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
Oncotarget. 2017;8(29): 47595-47606; Rinaldetti S, Wirtz RM, Worst TS, Eckstein M, Weiss CA, Breyer J, Otto W, Bolenz C, Hartmann A, Erben P

Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score
Transl Androl Urol. 2017;6(5): 991-993; Breyer J

High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer
Transl Oncol. 2017;10(3): 340-345; Sikic D, Breyer J, Hartmann A, Burger M, Erben P, Denzinger S, Eckstein M, Stöhr R, Wach S, Wullich B, Keck B, Wirtz RM, Otto W

ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ
Urol Int. 2017;98(3): 282-289; Breyer J, Otto W, Wirtz RM, Wullich B, Keck B, Erben P, Kriegmair MC, Stoehr R, Eckstein M, Laible M, Schlombs K, Eidt S, Denzinger S, Burger M, Hartmann A, BRIDGE Consortium

Solifenacin in the Elderly: Results of an Observational Study Measuring Efficacy, Tolerability and Cognitive Effects
Urol Int. 2017;98(3): 350-357; Hampel C, Betz D, Burger M, Nowak C, Vogel M

p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models
Urol Oncol. 2017; Morshaeuser L, May M, Burger M, Otto W, Hutterer GC, Pichler M, Klatte T, Wild P, Buser L, Brookman-May S

The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma
Urol Oncol. 2017;35(12): 671.e17-671.e23, Rink M, Engel O, Gakis G, Fritsche HM, Vetterlein MW, Soave A, Peine S, Aziz A, Dahlem R, Stenzl A, Burger M, Shariat SF, Fisch M, Gild P

Prerequisites, skills and productivity of young academic urologists in Germany
Urologe A. 2017;56(12): 1603-1610; Borgmann H, Bründl J, Huber J, Ruf C, Schagdarsurgengin U, Wullich B, Salem J

Is surgical treatment ever indicated in metastatic renal cell carcinoma and if so, based on which scientific rationale?
Urologe A. 2017;56(5): 617-623;  Burger M

What is the perception of the 10-point plan of the German Federal Ministry of Health against multidrug-resistant pathogens and measures of antibiotic stewardship? : An interdisciplinary analysis among German clinicians and development of a decision tool for urologists
Urologe A. 2017; May M, Vetterlein MW, Wagenlehner FM, Brookman-May SD, Gilfrich C, Fritsche HM, Spachmann PJ, Burger M, Schostak M, Lebentrau S, MR2-Studiengruppe

In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival
Virchows Arch. 2017;470(3): 267-274; Breyer J, Wirtz RM, Otto W, Erben P, Kriegmair MC, Stoehr R, Eckstein M, Eidt S, Denzinger S, Burger M, Hartmann A, BRIDGE Consortium

The German linguistic validation of the Ureteral Stent Symptoms Questionnaire (USSQ)
World J Urol. 2017;35(3): 443-447; Abt D, Dötzer K, Honek P, Müller K, Engeler DS, Burger M, Schmid HP, Knoll T, Sanguedolce F, Joshi HB, Fritsche HM

Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III
World J Urol. 2017;35(5): 737-744; Bach T, Bastian PJ, Blana A, Kaminsky A, Keller S, Knoll T, Lang C, Promnitz S, Ubrig B, Keller T, Qvick B, Burger M, OPTIC III Study Group , Shabayev A, Bick A, Hamza A, Blana A, Secker A, Lorch B, Hoschke B, Gilfrich C, Wülfing C, Lang C, Wiesner C, Fahlenkamp D, Scheer D, Diefenbach G, Wechsel HW, Leyh H, Sperling H, Manka L, Grimm MO, Funk M, Wille S, Wöhr M, Rink M, Wustmann R, Olianas R, Steiner R, Flühr R, Machtens S, Vögele S, Klotz T

Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
World J Urol. 2017;35(2): 245-250; May M, Fritsche HM, Vetterlein MW, Bastian PJ, Gierth M, Nuhn P, Aziz A, Fisch M, Stief CG, Hohenfellner M, Wirth MP, Novotny V, Hakenberg OW, Noldus J, Gilfrich C, Bolenz C, Burger M, Brookman-May SD, PROMETRICS 2011 Research Group , Bartsch G, Bolenz C, Buchner A, Chun F, Dahlem R, Durschnabel M, Ellinger J, Froehner M, Georgieva G, Gördük M, Grimm M, Grimm T, Hadaschik B, Haferkamp A, Hartmann F, Herrmann E, Janetschek G, Karl A, Keck B, Kraischits N, Krausse A, Lusuardi L, Martini T, Mayr R, Michel M, Moritz R, Müller S, Nuhn P, Pahernik S, Palisaar R, Ponholzer A, Protzel C, Pycha A, Rink M, Roghmann F, Roigas J, Schmid M, Schramek P, Seitz C, Shariat S, Sikic D, Syring I, Vallo S, Wagenlehner F, Wullich B

Bicentric prospective evaluation of corporoplasty with porcine small intestinal submucosa (SIS) in patients with severe Peyronie's disease
World J Urol. 2017;35(7): 1119-1124; Sayedahmed K, Rosenhammer B, Spachmann PJ, Burger M, Aragona M, Kaftan BT, Olianas R, Fritsche HM

Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
World J Urol. 2017;35(3): 379-387; Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, Spiess PE, Lotan Y, Ye D, Fernández MI, Kikuchi E, Chade DC, Babjuk M, Grollman AP, Thalmann GN

Do General Surgeons Feel Adequately Prepared for the Complex Questions Associated with the Handling of Multi-Resistant Pathogens? - Results of the MR2 Survey
Zentralbl Chir. 2017;142(3): 297-305; May M, Spachmann PJ, Lebentrau S, Schumacher H, Gilfrich C, Fritsche HM, Vetterlein M, Brookman-May S, Schostak M, Wagenlehner FM, Burger M, Novotny A, Obermaier R

 

2016

2015

Anamnesis, Pathological Assessment, Therapeutic Features and Course of Disease: Retrospective Study on Clinical-Based Factors for Prediction of Cancer-Specific Survival of 378 Patients with Stage pT1 Urothelial Bladder Carcinoma
Aktuelle Urol. 2015;46(3): 221-6 Breyer J, Otto W, Hartmann A, Bumes B, Bründl J, Gierth M, Bertz S, Denzinger S, Burger M, Lausenmeyer EM

2014

Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer.
Am J Clin Pathol. 2014;142(5): 634-9; Giedl J, Schneckenpointner R, Filbeck T, Ruemmele P, Hofstaedter F, Burger M, Hartmann A, Stoehr R

Body mass index has no impact on sperm quality but on reproductive hormones levels.
Andrologia. 2014;46(2): 106-11, M Al-Ali B, Gutschi T, Pummer K, Zigeuner R, Brookman-May S, Wieland WF, Fritsche HM, Aziz A

Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy.
Ann Surg Oncol. 2014;21(12): 4034-40, May M, Brookman-May S, Burger M, Gilfrich C, Fritsche HM, Rink M, Chun F, Fisch M, Roghmann F, Noldus J, Mayr R, Pycha A, Novotny V, Wirth M, Vallo S, Haferkamp A, Roigas J, Brisuda A, Stredele R, Volkmer B, Dechet C, Schnabel M,Denzinger S, Stief CG, Bastian PJ, Aziz A

Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer?
Ann Surg Oncol. 2014;Schmid M, Rink M, Traumann M, Bastian PJ, Bartsch G, Ellinger J, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Aziz A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, Gierth M, Pahernik SH, Protzel C, Roigas J, Gördük M, Lusuardi L, May M, Trinh QD, Fisch M, Chun FK, PROMETRICS 2011 Research Group

MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype.
Anticancer Res. 2014;34(5): 2255-61; Steurer S, Seddiqi AS, Singer JM, Bahar AS, Eichelberg C, Rink M, Dahlem R, Huland H, Sauter G, Simon R, Minner S, Burandt E, Stahl PR, Schlomm T, Wurlitzer M, Schlüter H

Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?
Cancer. 2014;120(1): 7-10; Becker A, Eichelberg C, Sun M

Predictors of survival in patients with disease recurrence after radical nephroureterectomy.
BJU Int. 2014;113(6): 911-7;Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Ikeda M, Matsumoto K, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B, Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Rouprêt M, Tagawa ST, Chun FK, Scherr DS, Vickers AJ, Shariat SF

Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
BJU Int. 2014;Lucca I, Rouprêt M, Kluth L, Rink M, Tilki D, Fajkovic H, Kassouf W, Hofbauer SL, de Martino M, Karakiewicz PI, Briganti A, Trinh QD, Seitz C, Fritsche HM, Burger M, Lotan Y, Kramer G, Shariat SF, Klatte T

Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.
Carcinogenesis. 2014;35(3): 727-36;Rose M, Gaisa NT, Antony P, Fiedler D, Heidenreich A, Otto W, Denzinger S, Bertz S, Hartmann A, Karl A, Knüchel R, Dahl E

EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer.
Clin Genitourin Cancer. 2014;12(4): 278-86; May M, Burger M, Brookman-May S, Stief CG, Fritsche HM, Roigas J, Zacharias M, Bader M, Mandel P, Gilfrich C, Seitz M, Tilki D

Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy.
Eur J Cancer. 2014;50(15): 2583-91; Gakis G, Fritsche HM, Hassan F, Kluth L, Miller F, Soave A, Otto W, Schwentner C, Todenhöfer T, Dahlem R, Burger M, Fisch M, Stenzl A, Aziz A, Rink M

Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.
Eur Urol. 2014;66(1): 156-63;Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, Rink M, Chun F, Martini T, Bolenz C, Mayr R, Pycha A, Nuhn P, Stief C, Novotny V, Wirth M, Seitz C, Noldus J, Gilfrich C, Shariat SF, Brookman-May S, Bastian PJ, Denzinger S, Gierth M, Roghmann F, PROMETRICS 2011 research group

Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Eur Urol. 2014;65(1): 218-26;Bertz S, Otto W, Denzinger S, Wieland WF, Burger M, Stöhr R, Link S, Hofstädter F, Hartmann A

Computerized quantification and planimetry of prostatic capsular nerves in relation to adjacent prostate cancer foci.
Eur Urol. 2014;65(4): 802-8;Bründl J, Schneider S, Weber F, Zeman F, Wieland WF, Ganzer R

Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
Eur Urol. 2014;65(3): 650-8; Xylinas E, Kluth L, Passonni N, Trinh QD, Rieken M, Lee RK, Fajkovic H, Novara G, Margulis V, Raman JD, Lotan Y, Rouprêt M, Aziz A, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Walton T, Karakiewicz PI, Montorsi F, Zerbib M, Scherr DS, Shariat SF, for the UTUC Collaboration

Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Eur Urol. 2014;65(1): 210-7;Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF, for the Upper Tract Urothelial Carcinoma Collaboration

Radical cystectomy and the implications of comorbidity.
Expert Rev Anticancer Ther. 2014;14(3): 289-95;Mayr R, Fritsche HM, Pycha A, Pycha A

Diagnostic and prognostic impact of peritumoral stromal remodeling in patients with surgically treated invasive penile squamous cell cancer.
Hum Pathol. 2014;45(6): 1169-76;Gunia S, Jain A, Albrecht K, Koch S, Otto W, Denzinger S, Götz S, Niessl N, Burger M, May M

Editorial comment to obese patients undergoing cystectomy: a population-based, propensity score matched analysis.
Int J Urol. 2014;21(5): 495-6; Gierth M, Burger M

Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
Int J Urol. 2014;21(10): 974;Lodde M, Mian C, Mayr R, Comploj E, Trenti E, Melotti R, Campodonico F, Maffezzini M, Fritsche HM, Pycha A

Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
Int J Urol. 2014;21(10): 968-72; Lodde M, Mian C, Mayr R, Comploj E, Trenti E, Melotti R, Campodonico F, Maffezzini M, Fritsche HM, Pycha A

Antiplatelet and anticoagulative medication during shockwave lithotripsy.
J Endourol. 2014;28(9): 1034-9; Schnabel MJ, Gierth M, Bründl J, Chaussy CG, Burger M, Fritsche HM

Do young patients with renal cell carcinoma feature a distinct outcome after surgery? A comparative analysis of patient age based on the multinational CORONA database.
J Urol. 2014;191(2): 310-5;Aziz A, May M, Zigeuner R, Pichler M, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Fenske F, Sountoulides P, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Wieland WF, Salzano L, Lotrecchiano G, Waidelich R, Stief C, Brookman-May S, Members of the CORONA Project and the Young Academic Urologists Renal Cancer Group

Anatomical Study of Pelvic Nerves in Relation to Seminal Vesicles, Prostate and Urethral Sphincter: Immunohistochemical Staining, Computerized Planimetry and 3-Dimensional Reconstruction.
J Urol. 2014; Ganzer R, Stolzenburg JU, Neuhaus J, Weber F, Fuchshofer R, Burger M, Bründl J

Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
J Urol. 2014;191(2): 316-22; Rink M, Sharifi N, Fritsche HM, Aziz A, Miller F, Kluth LA, Ngamsri T, Dahlem R, Chun FK, Shariat SF, Stenzl A, Fisch M, Gakis G

Interstitial lung disease during targeted therapy in metastatic renal cell carcinoma: a case series from three centres.
Med Oncol. 2014;31(9): 147; Ivanyi P, Fuehner T, Adam M, Eichelberg C, Herrmann E, Merseburger AS, Ganser A, Grünwald V

Mdm2 SNP309 G-variant is associated with invasive growth of human urinary bladder cancer.
Pathobiology. 2014;81(2): 53-9;Hitzenbichler F, Stoehr CG, Rogenhofer M, Wieland WF, Ruemmele P, Hartmann A, Stoehr R

Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Urol Int. 2014;93(3): 352-60;Aziz A, Rink M, Gakis G, Kluth LA, Dechet C, Miller F, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Fisch M, Burger M, Fritsche HM

Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study.
Urol Int. 2014;Aziz A, Madersbacher S, Otto W, Mayr R, Comploj E, Pycha A, Denzinger S,Fritsche HM, Burger M, Gierth M

Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients.
Urol Int. 2014;93(3): 311-9;Breyer J, Denzinger S, Otto W, Bründl J, Gierth M, Fritsche HM, Rößler W, Wieland WF, Giedl C, Hofstädter F, Rubenwolf P, Burger M, Aziz A

Frozen section analysis of ureteral margins in patients undergoing radical cystectomy for bladder cancer: differential impact of carcinoma in situ in the bladder on reliability and impact on tumour recurrence in the upper urinary tract.
Urol Int. 2014;92(1): 50-4; Loeser A, Katzenberger T, Vergho DC, Kocot A, Burger M, Riedmiller H

The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder.
Urol Int. 2014;93(3): 303-10;Mayr R, May M, Burger M, Martini T, Pycha A, Dechet C, Lodde M, Comploj E, Wieland WF, Denzinger S, Otto W, Aziz A, Fritsche HM, Gierth M

Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
Urol Oncol. 2014;Aziz A, Fritsche HM, Gakis G, Kluth LA, Al-Sayed Hassan F, Engel O, Dahlem R, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Shariat SF, Fisch M, Burger M, Rink M

Incidence and risk factors of renal hematoma: a prospective study of 1,300 SWL treatments.
Urolithiasis. 2014;42(3): 247-53;Schnabel MJ, Gierth M, Chaussy CG, Dötzer K,Burger M, Fritsche HM

Urethralcondylomata acuminata..
Urologe A. 2014;Brummeisl W, Lausenmeyer E, Weber F, Bründl J, Fritsche HM, Burger M, Denzinger S

Prostate surgery within residency programs in urology..
Urologe A. 2014;53(3): 379-81;Bründl J, Zengerling F, Borgmann H, Syring I

Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database.
Urologe A. 2014;53(2): 228-35;May M, Zigeuner R, Aziz A, Cindolo L, Gilfrich C, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Hoschke B, Dalpiaz O, Stoltze A, Fenske F, Fritsche HM, Chromecki T, Lebentrau S, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief CG, Brookman-May S, Mitglieder des "CORONA projects" , Projektgruppe "Young Academic Urologists Renal

Circumcision and orchiopexy: management of complications.
Urologe A. 2014;53(5): 663-70; Promm M, Rösch WH

Research fellowships and grants for young urologists.
Urologe A. 2014;53(10): 1533-4; Schneidewind L, Borgmann H, Bründl J, Salem J

Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis.
Urology. 2014;83(4): 863-7;Messer JC, Shariat SF, Dinney CP, Novara G, Fradet Y, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Lotan Y, Skinner EC, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Wei C, Lerner SP, Curiel TJ, Kamat AM, Svatek RS

Is the striated urethral sphincter at risk by standard suture ligation of the dorsal vascular complex in radical prostatectomy? An anatomic study.
Urology. 2014;84(6): 1453-60;Ganzer R, Stolzenburg JU, Neuhaus J, Weber F, Burger M, Bründl J

Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption.
Urology. 2014;83(6): 1285-91; Becker A, Ravi P, Roghmann F, Trinh QD, Tian Z, Larouche A, Kim S, Shariat SF, Kluth L, Dahlem R, Fisch M, Graefen M, Eichelberg C, Karakiewicz PI, Sun M

Efficacy and tolerability of solifenacin in men with overactive bladder: results of an observational study.
World J Urol. 2014;32(4): 1041-7;Burger M, Betz D, Hampel C, Vogel M

Correlation of pretreatment clinical parameters and PSA nadir after high-intensity focused ultrasound (HIFU) for localised prostate cancer.
World J Urol. 2014; Ganzer R, Bründl J, Koch D, Wieland WF, Burger M, Blana A

Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.
World J Urol. 2014;32(2): 365-71;Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M

The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder.
World J Urol. 2014;Gierth M, Aziz A, Fritsche HM, Burger M, Otto W, Zeman F, Pawlik MT, Hansen E, May M, Denzinger S

Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series.
World J Urol. 2014; May M, Aziz A, Brookman-May S, Roghmann F, Noldus J, Rink M, Chun F, Fisch M, Novotny V, Wirth M, Mayr R, Pycha A, Brisuda A, Volkmer B, Stredele R, Dechet C, Vallo S, Haferkamp A, Schnabel M, Denzinger S, Roigas J, Stief CG, Gilfrich C, Bastian PJ, Engel JB, Burger M, Fritsche HM

Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study.
World J Urol. 2014; Nuhn P, Novara G, Seitz C, Gupta A, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Tritschler S, Martínez-Salamanca JI, Ficarra V, Karakiewicz PI, Mazzoleni G, Shariat SF, Bastian PJ

Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional study.
World J Urol. 2014;32(4): 911-6;Ponholzer A, Trubel S, Schramek P, Wimpissinger F, Feichtinger H, Springer C, Wehrberger C, Fischereder K, Pummer K, Martini T, Mayr R, Pycha A, Madersbacher S

Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage.
World J Urol. 2014;32(4): 991-7; Rubenwolf PC, Otto W, Denzinger S, Hofstädter F, Wieland W, Georgopoulos NT

Prospective evaluation of intra-observer variability of the hydronephrosis index in sonographic examination of 44 patients with acute renal colic.
World J Urol. 2014;32(3): 691-5;Rud O, Horstmann M, Aziz A, Fritsche HM, Brookman-May S, Gilfrich C, Burger M, May M

The Post-Ureteroscopic Lesion Scale (PULS): a multicenter video-based evaluation of inter-rater reliability.
World J Urol. 2014;32(4): 1033-40; Schoenthaler M, Buchholz N, Farin E, Ather H, Bach C, Bach T, Denstedt JD, Fritsche HM, Grasso M, Hakenberg OW, Herwig R, Knoll T, Kuehhas FE, Liatsikos E, Liske P, Marberger M, Osther PJ, Santos JM, Sarica K, Seitz C, Straub M, Traxer O, Trinchieri A, Turney B, Miernik A

Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer..
World J Urol. 2014; Vergho D, Burger M, Schrammel M, Brookman-May S, Gierth M, Hoschke B, Lopau K, Gilfrich C, Riedmiller H, Wolff I, May M

Laparoscopic versus open partial nephrectomy for clinical T1 renal masses: no impact of surgical approach on perioperative complications and long-term postoperative quality of life.
World J Urol. 2014; Becker A, Pradel L, Kluth L, Schmid M, Eichelberg C, Ahyai S, Trinh Q, Seiler D, Dahlem R, Hansen J, Rink M, Zacharias M, Mehnert A, Bergelt C, Fisch M, Chun FK

2013

Predictors of survival in patients with softtissuesurgicalmargininvolvement at radicalcystectomy.
Ann Surg Oncol. 2013;20(3): 1027-34
Xylinas E, Rink M, Novara G, Green DA, Clozel T, Fritsche HM, Guillonneau B, Lotan Y, Kassouf W, Tilki D, Babjuk M, Karakiewicz PI, Montorsi F, Abdennabi J, Trinh QD, Svatek RS, Scherr DS, Zerbib M, Shariat SF

Obesity is associated with worseoncologicaloutcomes in patientstreated with radicalcystectomy.
BJU Int. 2013;111(2): 249-55
Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF

Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.
BJU Int. 2013;112(3): 322-9
Ganzer R, Fritsche HM, Brandtner A, Bründl J, Koch D, Wieland WF, Blana A

PREDICTORS OF SURVIVAL IN PATIENTS WITH DISEASE RECURRENCE FOLLOWING RADICAL NEPHROURETERECTOMY.
BJU Int. 2013;
Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Matsumoto K, Ikeda M, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B, Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Rouprêt M, Tagawa ST, Chun FK, Scherr DS, Vickers A, Shariat SF

Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
BJU Int. 2013;112(4): E383-90
May M, Burger M, Otto W, Hakenberg OW, Wieland WF, May D, Hofstädter F, Götz S, Niessl N, Fritsche HM, Birnkammer K, Gilfrich C, Peter J, Jain A, Koch S, Lebentrau S, Riedmiller H, Rössler W, Denzinger S, Brookman-May S, Gunia S

Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
BJU Int. 2013;111(1): 74-84
Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF

Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
BJU Int. 2013;111(3b): E30-E36
Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF, for the Bladder Cancer Research Consortium

Isolated bladder exstrophy associated with a de novo 0.9 Mb microduplication on chromosome 19p13.12.
Birth Defects Res A Clin Mol Teratol. 2013;97(3): 133-9
Draaken M, Mughal SS, Pennimpede T, Wolter S, Wittler L, Ebert AK, Rösch W, Stein R, Bartels E, Schmidt D, Boemers TM, Schmiedeke E, Hoffmann P, Moebus S, Herrmann BG, Nöthen MM, Reutter H, Ludwig M

Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.
Carcinogenesis. 2013
Rose M, Gaisa NT, Antony P, Fiedler D, Heidenreich A, Otto W, Denzinger S, Bertz S, Hartmann A, Karl A, Knüchel R, Dahl E

EORTC Progression Score Identifies Patients at High Risk of Cancer-Specific Mortality After Radical Cystectomy for Secondary Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer. 2013;
May M, Burger M, Brookman-May S, Stief CG, Fritsche HM, Roigas J, Zacharias M, Bader M, Mandel P, Gilfrich C, Seitz M, Tilki D

Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients.
Clin Genitourin Cancer. 2013; Dec;11(4):537-44
Otto W, Denzinger S, Fritsche HM, Burger M, Rößler W, Bertz S, May M, Hartmann A, Hofstädter F, Wieland WF, Eder F

Value of fluorescence cystoscopy in high risk non-muscle invasive bladder cancer
Curr Urol Rep. 2013;14(2): 90-3
Mayr R, Burger M

Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks
Eur J Surg Oncol. 2013;39(4): 372-9
Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, Gilfrich C, Roigas J, Zacharias M, Hohenfellner M, Haferkamp A, Trojan L, Wieland WF, Müller SC, Stief CG, Bastian PJ

Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort.
Eur Urol. 2013;
Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, Rink M, Chun F, Martini T, Bolenz C, Mayr R, Pycha A, Nuhn P, Stief C, Novotny V, Wirth M, Seitz C, Noldus J, Gilfrich C, Shariat SF, Brookman-May S, Bastian PJ, Denzinger S, Gierth M, Roghmann F, PROMETRICS 2011 research group

Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database
Eur Urol. 2013;64(3): 472-7
Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, members of the CORONA project and the SATURN project

Computerized Quantification and Planimetry of Prostatic Capsular Nerves in Relation to Adjacent Prostate Cancer Foci.
Eur Urol. 2013
Bründl J, Schneider S, Weber F, Zeman F, Wieland WF, Ganzer R

ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder.
Eur Urol. 2013;63(1): 36-44
Burger M, Oosterlinck W, Konety B, Chang S, Gudjonsson S, Pruthi R, Soloway M, Solsona E, Sved P, Babjuk M, Brausi MA, Cheng C, Comperat E, Dinney C, Otto W, Shah J, Thürof J, Witjes JA

Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.
Eur Urol. 2013;63(4): 739-44
Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M

Reply to Michael Froehner, Rainer Koch and Manfred P. Wirth's letter to the editor re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012;62:662-70.
Eur Urol. 2013;63(1): e10
Mayr R, May M, Fritsche HM

Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
Eur Urol. 2013;63(2): 371-8
Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS, Svatek RS, Cha EK, Tagawa ST, Fajkovic H, Novara G, Karakiewicz PI, Trinh QD, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Chun FK, Sonpavde G, Joual A, Scherr DS, Gonen M

Lymphadenectomy for bladder cancer at the time of radical cystectomy.
Eur Urol. 2013;64(2): 266-76
Tilki D, Brausi M, Colombo R, Evans CP, Fradet Y, Fritsche HM, Lerner SP, Sagalowsky A, Shariat SF, Bochner BH

Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool.
Eur Urol. 2013;
Xylinas E, Kluth L, Passonni N, Trinh QD, Rieken M, Lee RK, Fajkovic H, Novara G, Margulis V, Raman JD, Lotan Y, Rouprêt M, Aziz A, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Walton T, Karakiewicz PI, Montorsi F, Zerbib M, Scherr DS, Shariat SF, for the UTUC Collaboration

The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer.
FEBS J. 2013;280(9): 2105-16
Hart M, Wach S, Nolte E, Szczyrba J, Menon R, Taubert H, Hartmann A, Stoehr R, Wieland W, Grässer FA, Wullich B

Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis.
Hum Pathol. 2013;44(5): 712-7
Gunia S, Erbersdobler A, Koch S, Otto W, Stabiano S, D Alterio C, Brookman-May S

Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma.
Int J Cancer. 2013;132(4): 775-84
Szczyrba J, Nolte E, Hart M, Döll C, Wach S, Taubert H, Keck B, Kremmer E, Stöhr R, Hartmann A, Wieland W, Wullich B, Grässer FA

Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy.
Int J Urol. 2013;20(9): 866-71
Buse S, Höfner T, Müller SC, Hermann E, Wieland WF, May M, Stief CG, Bastian PJ, Hohenfellner M, Haferkamp A

Editorial Comment to Obese patients undergoing cystectomy: A population-based, propensity score matched analysis.
Int J Urol. 2013;
Gierth M, Burger M

Do Young Patients with Renal Cell Carcinoma Feature a Distinct Outcome after Surgery? A Comparative Analysis of Patient Age Based on the Multinational CORONA Database.
J Urol. 2014 Feb;191(2):310-5.
Aziz A, May M, Zigeuner R, Pichler M, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Fenske F, Sountoulides P, Figenshau RS, Madison K, Sánchez-Chapado M, Martin MD, Wieland WF, Salzano L, Lotrecchiano G, Waidelich R, Stief C, Brookman-May S, Members of the CORONA project and the Young Academic Urologists Renal Cancer Group

Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.
J Urol. 2013;190(2): 458-63
May M, Ficarra V, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Burger M, Gunia S, Feciche B, Wenzl V, Aziz A, Chun F, Becker A, Pahernik S, Simeone C, Longo N, Zucchi A, Antonelli A, Mirone V, Stief C, Novara G, Brookman-May S, CORONA and SATURN projects , Young Academic Urologists Renal Cancer Group

Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
J Urol. 2014 Feb;191(2):316-22
Rink M, Sharifi N, Fritsche HM, Aziz A, Miller F, Kluth LA, Ngamsri T, Dahlem R, Chun FK, Shariat SF, Stenzl A, Fisch M, Gakis G

Histone methylation defines an epigenetic entity in penile squamous cell carcinoma.
J Urol. 2013;189(3): 1117-22
Rogenhofer S, Miersch H, Göke F, Kahl P, Wieland WF, Hofstädter F, Kristiansen G, von Ruecker A, Müller SC, Ellinger J

Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
J Urol. 2013;189(5): 1662-9
Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF, French National Database on Upper Tract Tumors , Upper Tract Urothelial Carcinoma Collaboration

Persistent histological changes in the exstrophic bladder after primary closure-a cause for concern?
J Urol. 2013;189(2): 671-7
Rubenwolf PC, Eder F, Ebert AK, Hofstaedter F, Woodhouse CR, Roesch WH

Assisted reproductive techniques and risk of exstrophy-epispadias complex: a German case-control study.
J Urol. 2013;189(4): 1524-9
Zwink N, Jenetzky E, Hirsch K, Reifferscheid P, Schmiedeke E, Schmidt D, Reckin S, Obermayr F, Boemers TM, Stein R, Reutter H, Rösch WH, Brenner H, Ebert AK

What is to be done in a case of weak urine flow?
MMW Fortschr Med. 2013;155(11): 47
Brummeisl W

Bladder cancer: Progress in defining progression in NMIBC.
Nat Rev Urol. 2013;10(12): 684-5
Gierth M, Burger M

Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.
Urol Int. 2013;91(1): 97-102
Aziz A, Gierth M, Fritsche HM, May M, Otto W, Denzinger S, Wieland WF, Merseburger A, Riedmiller H, Kocot A, Burger M

Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders' grading of penile squamous cell carcinomas.
Urol Int. 2013;90(2): 207-13
Gunia S, Burger M, Hakenberg OW, May D, Koch S, Jain A, Birnkammer K, Wieland WF, Otto W, Hofstädter F, Fritsche HM, Denzinger S, Gilfrich C, Brookman-May S, May M

Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder
Urol Oncol. 2013;31(4): 480-6
Kassouf W, Svatek RS, Shariat SF, Novara G, Lerner SP, Fradet Y, Bastian PJ, Aprikian A, Karakiewicz PI, Fritsche HM, Dinney CP, Tilki D, Kamat AM, Izawa JI, Ficarra V, Lotan Y, Sagalowsky AI, Schoenberg MP, Skinner EC

Focal prostate cancer therapy: capabilities, limitations and prospects.
Urologe A. 2013;52(4): 549-56
Baumunk D, Blana A, Ganzer R, Henkel T, Köllermann J, Roosen A, Machtens S, Salomon G, Sentker L, Witzsch U, Köhrmann KU, Schostak M, Arbeitsgruppe für Fokale und Mikrotherapie

Urinary bladder function disorders in childhood.
Urologe A. 2013;52(1): 15-6, 18-20
Geyer VC, Ebert AK, Rösch WH

Intrascrotal lipoblastoma in childhood: diagnostic strategies and therapy planning.
Urologe A. 2013;52(12): 1708-11
Promm M, Reingruber B, Rösch WH

Male circumcision is not associated with an increased prevalence of erectile dysfunction: results of the Cottbus 10,000-men survey.
Urologe A. 2013;52(4): 562-9
Hoschke B, Fenske S, Brookman-May S, Spivak I, Gilfrich C, Fritsche HM, Wolff I, May M

Postoperative prognosis of chromophobic renal cell carcinoma : Comparative analysis of the multinational CORONA database.
Urologe A. 2013;
May M, Zigeuner R, Aziz A, Cindolo L, Gilfrich C, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Hoschke B, Dalpiaz O, Stoltze A, Fenske F, Fritsche HM, Chromecki T, Lebentrau S, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief CG, Brookman-May S, Mitglieder des ,,CORONA projects" und/oder der Projektgruppe ,,Young Academic Urologists Renal Cancer Group" der European Association of Urology (EAU)

Delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (Deflux) injection for treatment of vesicoureteral reflux in children: a case series.
Urology. 2013;81(3): 659-62
Rubenwolf PC, Ebert AK, Ruemmele P, Rösch WH

Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.
World J Urol. 2013;31(1): 5-11
Fajkovic H, Cha EK, Xylinas E, Rink M, Pycha A, Seitz C, Bolenz C, Dunning A, Novara G, Trinh QD, Karakiewicz PI, Margulis V, Raman JD, Walton TJ, Baba S, Carballido J, Otto W, Montorsi F, Lotan Y, Kassouf W, Fritsche HM, Bensalah K, Zigeuner R, Scherr DS, Sonpavde G, Roupret M, Shariat SF

Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.
World J Urol. 2013
Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M

Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.
World J Urol. 2013;
May M, Aziz A, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Stoltze A, Fenske F, Fritsche HM, Figenshau RS, Madison K, Sánchez-Chapado M, Martin MD, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief C, Brookman-May S, Members of the CORONA project the Young Academic Urologists Renal Cancer Group

Prospective evaluation of intra-observer variability of the hydronephrosis index in sonographic examination of 44 patients with acute renal colic.
World J Urol. 2013;
Rud O, Horstmann M, Aziz A, Fritsche HM, Brookman-May S, Gilfrich C, Burger M, May M

The Post-Ureteroscopic Lesion Scale (PULS): a multicenter video-based evaluation of inter-rater reliability.
World J Urol. 2013;
Schoenthaler M, Buchholz N, Farin E, Ather H, Bach C, Bach T, Denstedt JD, Fritsche HM, Grasso M, Hakenberg OW, Herwig R, Knoll T, Kuehhas FE, Liatsikos E, Liske P, Marberger M, Osther PJ, Santos JM, Sarica K, Seitz C, Straub M, Traxer O, Trinchieri A, Turney B, Miernik A

2012

Predictive Value of Positive Surgical Margins after Radical Prostatectomy for Lymph Node Metastasis in Locally Advanced Prostate Carcinoma
Adv Urol. 2012;2012: 618574
Otto W, Gerber P, Rößler W, Wieland WF, Denzinger S

A rare location of metastasis from prostate cancer: hydronephrosis associated with ureteral metastasis.
Adv Urol. 2012;2012: 656023
Schneider S, Popp D, Denzinger S, Otto W

HIFU in salvage treatment of patients with prostate cancer after primary external radiation therapy--status 2012].
Aktuelle Urol. 2012;43(5): 330-6
Baumunk D, Cash H, Ebbing J, Porsch M, Janitzky A, Wendler JJ, Liehr UB, Ganzer R, Blana A, Schostak M

Tumour registry and reality: differential diagnosis of testicular tumours in childhood: survey and personal experience].
Aktuelle Urol. 2012;43(2): 104-11
Ebert AK, Neisser C, Rösch WH

Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a German high-volume clinic.
Aktuelle Urol. 2012;43(3): 162-6
Otto W, Nowrotek A, Burger M, Wieland WF, Rößler W, Denzinger S

Body mass index has no impact on sperm quality but on reproductive hormones levels.
Andrologia. 2012;
M Al-Ali B, Gutschi T, Pummer K, Zigeuner R, Brookman-May S, Wieland WF, Fritsche HM, Aziz A

Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy
Ann Surg Oncol. 2013 Mar;20(3):1027-34
Xylinas E, Rink M, Novara G, Green DA, Clozel T, Fritsche HM, Guillonneau B, Lotan Y, Kassouf W, Tilki D, Babjuk M, Karakiewicz PI, Montorsi F, Abdennabi J, Trinh QD, Svatek RS, Scherr DS, Zerbib M, Shariat SF

Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer.
Anticancer Res. 2012;32(8): 3479-83
Rogenhofer S, Ellinger J, Kahl P, Stoehr C, Hartmann A, Engehausen D, Wieland WF, Müller SC, Hofstädter F, Walter B

Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
BJU Int. 2013 Feb;111(2):249-55;
Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF

Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study.
BJU Int. 2012;109(8): 1155-1161
Martinez-Salamanca JI, Shariat SF, Rodriguez JC, Chromecki TF, Ficarra V, Fritsche HM, Kassouf W, Matsumoto K, Cabello LO, Seitz C, Tritschler S, Walton TJ, Zattoni F, Novara G

Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder.
BJU Int. 2012;110(6 Pt B): E222-7
Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM 

Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
BJU Int. 2013 Mar;111(3b)
Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF, for the Bladder Cancer Research Consortium

International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
BJU Int. 2012;110(5): 674-81
Roscigno M, Cha EK, Rink M, Seitz C, Novara G, Chromecki TF, Fritsche HM, Matsumoto K, Walton TJ, Carballido J, Filippo Da Pozzo L, Bertini R, Ficarra V, Otto W, Karakiewicz PI, Pycha A, Fajkovic H, Naspro R, Scherr DS, Montorsi F, Shariat SF

Prospective evaluation of interobserver variability of the hydronephrosis index and the renal resistive index as sonographic examination methods for the evaluation of acute hydronephrosis.
BJU Int. 2012;110(8 Pt B): E350-6
Rud O, Moersler J, Peter J, Waliszewski P, Gilfrich C, Häuser H, Burger M, Fritsche HM, Wieland WF, Ahmed AM, Brookman-May S, May M

Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
BJU Int. 2012;110(2b): E7-E13
Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W

Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer.
BMC Cancer. 2012;12(1): 459
Otto W, Rubenwolf PC, Burger M, Fritsche HM, Rößler W, May M, Hartmann A, Hofstädter F, Wieland WF, Denzinger S

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.
Br J Cancer. 2012;107(11): 1826-32
Xylinas E, Cha EK, Sun M, Rink M, Trinh QD, Novara G, Green DA, Pycha A, Fradet Y, Daneshmand S, Svatek RS, Fritsche HM, Kassouf W, Scherr DS, Faison T, Crivelli JJ, Tagawa ST, Zerbib M, Karakiewicz PI, Shariat SF

A patient with fibroepithelial polyp of the ureter-a rare condition mimicking malignancy: a case report.
Case Rep Urol. 2012;2012: 901693
Brummeisl W, Fritsche HM, Huber E, Wieland WF, Ganzer R

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Eur J Surg Oncol. 2012;38(7): 637-42
Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, Wülfing C, May F, Melchior S, Haferkamp A, Gilfrich C, Hohenfellner M, Wieland WF, Müller SC, Stief CG, Bastian PJ

Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer.
Eur Urol. 2012;
Bertz S, Otto W, Denzinger S, Wieland WF, Burger M, Stöhr R, Link S, Hofstädter F, Hartmann A

Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project).
Eur Urol. 2012
Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, members of the CORONA project and the SATURN project

Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A new and highly prognostic system to discern T1 bladder cancer substage. Eur Urol 2012;61:378-84.
Eur Urol. 2012;61(4): e31-2; author reply e33-4
Burger M, Otto W, Hartmann A

Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma
Eur Urol. 2012;61(4): 818-25
Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V

Anatomic study of periprostatic nerve distribution: immunohistochemical differentiation of parasympathetic and sympathetic nerve fibres.
Eur Urol. 2012;
Ganzer R, Stolzenburg JU, Wieland WF, Bründl J

Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder.
Eur Urol. 2012;62(4): 662-70
Mayr R, May M, Martini T, Lodde M, Comploj E, Pycha A, Strobel J, Denzinger S, Otto W, Wieland W, Burger M, Fritsche HM

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Eur Urol. 2012;61(1): 58-64
Nuhn P, May M, Sun M, Fritsche HM, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, Tilki D, Trojan L, Perrotte P, Haferkamp A, Hohenfellner M, Wieland WF, Müller SC, Karakiewicz PI, Bastian PJ

Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
Eur Urol. 2012;62(4): 677-84
Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, Margulis V, Raman JD, Svatek RS, Fajkovic H, Lee RK, Novara G, Hansen J, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Fisch M, Scherr DS, Shariat SF, Bladder Cancer Research Consortium (BCRC) , Upper Tract Urothelial Carcinoma Collaboration (UTUCC) , Bastian PJ, Bensalah K, Bolenz C, Chromecki TF, Dinney CP, Fernández M, Ficarra V, Fradet Y, Izawa JI, Kabbani W, Kikuchi E, Koppie TM, Lerner SP, Martinez-Salamanca JI, Matsumoto K, Montorsi F, Ng CK, Oya M, Patard JJ, Remzi M, Roscigno M, Sagalowsky AI, Schoenberg MP, Seitz C, Skinner E, Ströbel P, Tilki D, Tritschler S, Walton TJ, Weizer A, Wolf J, Wood CG, Zigeuner R

Aquaporin 3 protein expression in transitional cell carcinoma: a potential marker with regard to tumour progression and prognosis?
Eur Urol. 2012;61(3): 627-8
Rubenwolf PC, Denzinger S, Otto W

Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
Eur Urol. 2012;61(2): 237-42
Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gonen M

Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Eur Urol. 2012;
Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF, for the Upper Tract Urothelial Carcinoma Collaboration

Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.
Gend Med. 2012;9(6): 481-9
Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M

Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis.
Hum Pathol. 2012;
Gunia S, Erbersdobler A, Koch S, Otto W, Stabiano S, D Alterio C, Brookman-May S

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.
Int J Cancer. 2012;130(3): 611-21
Wach S, Nolte E, Szczyrba J, Stöhr R, Hartmann A, Ørntoft T, Dyrskjøt L, Eltze E, Wieland W, Keck B, Ekici AB, Grässer F, Wullich B

Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma.
J Cancer Res Clin Oncol. 2012;138(2): 359-61
Stoehr CG, Stoehr R, Hartmann A, Hofstaedter F, Junker K, Blaszyk H, Wieland WF, Otto W, Denzinger S, Walter B

Sonographic diagnosis of a posttraumatic arteriocavernosal fistula resulting in high-flow priapism.
J Clin Ultrasound. 2012;40(1): 60-2
Keck B, Lotter G, Wieland WF, Wullich B, Uder M, Engehausen DG, Fritsche HM

Prediction of Cancer Specific Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Development of an Optimized Postoperative Nomogram Using Decision Curve Analysis.
J Urol. 2012 Oct 24.
Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF; French National Database on Upper Tract Tumors; Upper Tract Urothelial Carcinoma Collaboration. 

Testicular tumors in patients with exstrophy-epispadias complex.
J Urol. 2012;188(4): 1300-5
Ebert AK, Kliesch S, Neissner C, Reutter H, Rösch WH

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
J Urol. 2012;187(4): 1210-4
May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M

Assisted Reproductive Techniques and Risk of Exstrophy-Epispadias Complex: A German Case-Control Study.
J Urol. 2012;
Zwink N, Jenetzky E, Hirsch K, Reifferscheid P, Schmiedeke E, Schmidt D, Reckin S, Obermayr F, Boemers TM, Stein R, Reutter H, Rösch WH, Brenner H, Ebert AK

Transition of adolescents with the exstrophy-epispadias complex to adult medicine: influence of long-term outcome results on management.
Klin Padiatr. 2012;224(7): 455-60
Ebert AK, Reutter H, Neissner C, Rösch W

Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial.
Med Oncol. 2012;29(2): 799-805
Walter B, Schrettenbrunner I, Vogelhuber M, Grassinger J, Bross K, Wilke J, Suedhoff T, Berand A, Wieland WF, Rogenhofer S, Andreesen R, Reichle A

Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention.
Neuromodulation. 2012;
Denzinger S, Nowrotek A, Weingart P, Burger M, Wieland WF, Rößler W, Otto W

Mismatch repair proteins hMLH1 and hMSH2 are differently expressed in the three main subtypes of sporadic renal cell carcinoma.
Pathobiology. 2012;79(3): 162-8
Stoehr C, Burger M, Stoehr R, Bertz S, Ruemmele P, Hofstaedter F, Denzinger S, Wieland WF, Hartmann A, Walter B

Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry.
Prostate Cancer Prostatic Dis. 2012;15(3): 256-9
Blana A, Robertson CN, Brown SC, Chaussy C, Crouzet S, Gelet A, Conti GN, Ganzer R, Pasticier G, Thuroff S, Ward JF

Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning broders' grading of penile squamous cell carcinomas.
Urol Int. 2012;
Gunia S, Burger M, Hakenberg OW, May D, Koch S, Jain A, Birnkammer K, Wieland WF, Otto W, Hofstädter F, Fritsche HM, Denzinger S, Gilfrich C, Brookman-May S, May M

Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Urol Oncol. 2012;30(5): 666-72
Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF

Focal prostate cancer therapy : Capabilities, limitations and prospects.
Urologe A. 2012;
Baumunk D, Blana A, Ganzer R, Henkel T, Köllermann J, Roosen A, Machtens S, Salomon G, Sentker L, Witzsch U, Köhrmann KU, Schostak M, Arbeitsgruppe für Fokale und Mikrotherapie

Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens.
Virchows Arch. 2012;
Fritsche HM, Aziz A, Eder F, Otto W, Denzinger S, Wieland WF, May M, Hofstädter F, Hartmann A, Burger M

Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria.
Virchows Arch. 2012;460(3): 343-52
Walter B, Hartmann A, Hofstädter F, Junker K, Moch H, Bertz S, Denzinger S, Otto W, Gajda M, Stoehr CG

Should we abstain from Gleason score 2-4 in the diagnosis of prostate cancer? Results of a German multicentre study.
World J Urol. 2012;30(1): 97-103
Brookman-May S, May M, Wieland WF, Lebentrau S, Gunia S, Koch S, Gilfrich C, Roigas J, Hoschke B, Burger M

Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.
World J Urol. 2012;
Brookman-May S, May M, Ficarra V, Kainz MC, Kampel-Kettner K, Kohlschreiber S, Wenzl V, Schneider M, Burger M, Wieland WF, Otto W, Tilki D, Gilfrich C, Hohenfellner M, Pahernik S, Chromecki TF, Stief C, Zigeuner R, Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project

Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.
World J Urol. 2012;30(6): 753-9
Chromecki TF, Mauermann J, Cha EK, Svatek RS, Fajkovic H, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Novara G, Fritsche HM, Ficarra V, Stief CG, Dinney CP, Skinner E, Pummer K, Fradet Y, Shariat SF

Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.
World J Urol. 2012;
Fajkovic H, Cha EK, Xylinas E, Rink M, Pycha A, Seitz C, Bolenz C, Dunning A, Novara G, Trinh QD, Karakiewicz PI, Margulis V, Raman JD, Walton TJ, Baba S, Carballido J, Otto W, Montorsi F, Lotan Y, Kassouf W, Fritsche HM, Bensalah K, Zigeuner R, Scherr DS, Sonpavde G, Roupret M, Shariat SF

Prospective blinded comparison of real-time sonoelastography targeted versus randomised biopsy of the prostate in the primary and re-biopsy setting.
World J Urol. 2012;30(2): 219-23
Ganzer R, Brandtner A, Wieland WF, Fritsche HM

Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy.
World J Urol. 2012;30(6): 841-6
Lodde M, Mayr R, Martini T, Comploj E, Palermo S, Trenti E, Hanspeter E, Fritsche HM, Mian C, Pycha A

Gender-dependent cancer-specific survival following radical cystectomy.
World J Urol. 2012;30(5): 707-13
May M, Stief C, Brookman-May S, Otto W, Gilfrich C, Roigas J, Zacharias M, Wieland WF, Fritsche HM, Hofstädter F, Burger M

First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival.
World J Urol. 2012;30(6): 875-7
Otto W, Denzinger S, Wieland WF, Hartmann A

Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
World J Urol. 2012;30(6): 807-14 Rink M, Shariat SF, Xylinas E, Fitzgerald JP, Hansen J, Green DA, Kamat AM, Novara G, Daneshmand S, Fradet Y, Tagawa ST, Bastian PJ, Kassouf W, Trinh QD, Karakiewicz PI, Fritsche HM, Tilki D, Chun FK, Volkmer BG, Babjuk M, Merseburger AS, Scherr DS, Lotan Y, Svatek RS

Enhanced urothelial expression of human chorionic gonadotropin beta (hCGβ) in bladder pain syndrome/interstitial cystitis (BPS/IC).
World J Urol. 2012;30(3): 411-7
Schwalenberg T, Stolzenburg JU, Ho TP, Mallock T, Hartenstein S, Alexander H, Zimmermann G, Hohenfellner R, Denzinger S, Burger M, Horn LC, Neuhaus J

Utility of immunohistochemistry markers in the interpretation of post-high-intensive focussed ultrasound prostate biopsy cores.
World J Urol. 2012;
Walter B, Weiss T, Hofstädter F, Gaumann A, Hartmann A, Rogenhofer S, Ganzer R, Wach S, Engehausen D, Wieland WF, Blana A

2011

Difference between clinical and pathologic renal tumor size, correlation with survival, and implications for patient counseling regarding nephron-sparing surgery.
Brookman-May S, Johannsen M, May M, Hoschke B, Gunschera J, Wieland WF, Burger M.
AJR Am J Roentgenol. 2011 Nov;197(5):1137-45.

Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
Brookman-May S, May M, Zigeuner R, Shariat SF, Scherr DS, Chromecki T, Moch H, Wild PJ, Mohamad-Al-Ali B, Cindolo L, Wieland WF, Schips L, De Cobelli O, Rocco B, Santoro L, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Dalpiaz O, Hohenfellner M, Gilfrich C, Wirth MP, Burger M, Pahernik S; CORONA Project (Collaborative Research on Renal Neoplasms Association).
J Urol. 2011 Dec;186(6):2175-81.

Re: Todd M. Morgan, Dominic Tang, Kelly L. Stratton, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 2011;59:923-8. Re: Umberto Capitanio, Francesco Montorsi. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues. Eur Urol 2011;59:929-30.
Brookman-May S, Burger M, Wieland WF, May M.
Eur Urol. 2011 Nov;60(5):e45-6; author reply e47.

Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease.
Brookman-May S, Burger M, Wieland WF, Rössler W, May M, Denzinger S.
Expert Rev Vaccines. 2011 Jun;10(6):837-52. Review.

Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma.
Brookman-May S, Kendel F, Hoschke B, Wieland WF, Burger M, Rössler W, May M.
Scand J Urol Nephrol. 2011 Feb;45(1):5-14.

Transrectal high-intensity focused ultrasound for local treatment of prostate cancer: current role.
Chaussy CG, Thüroff S.
Arch Esp Urol. 2011 Jul;64(6):493-506. Review.

Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use?
Chaussy CG, Thüroff SF.
Curr Urol Rep. 2011 Jun;12(3):180-7. Review.

Shock wave technology and application: an update.
Rassweiler JJ, Knoll T, Köhrmann KU, McAteer JA, Lingeman JE, Cleveland RO, Bailey MR, Chaussy CG.
Eur Urol. 2011 May;59(5):784-96. Review.

Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series.
Denzinger S, Bertz S, Otto W, Wieland WF, Stoehr R, Hofstaedter F, Hartmann A.
Histopathology. 2011 Oct;59(4):722-32.

Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study.
Fritsche HM, Otto W, Eder F, Hofstädter F, Denzinger S, Chaussy CG, Stief C, Wieland WF, Burger M.
J Endourol. 2011 Oct;25(10):1599-603.

Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder.
May M, Bastian PJ, Burger M, Bolenz C, Trojan L, Herrmann E, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Otto W, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Fritsche HM.
BJU Int. 2011 Oct;108(8 Pt 2):E278-83.

Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder.
May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Fritsche HM.
Scand J Urol Nephrol. 2011 Sep;45(4):251-7.

Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.
Ganzer R, Robertson CN, Ward JF, Brown SC, Conti GN, Murat FJ, Pasticier G, Rebillard X, Thuroff S, Wieland WF, Blana A.
BJU Int. 2011 Oct;108(8 Pt 2):E196-201.

Anatomical description of the periprostatic nerves in the male rhesus monkey (Macaca mulatta).
Ganzer R, Neuhaus J, Gratzke C, Blana A, Wieland WF, Stolzenburg JU.
World J Urol. 2011 Jun;29(3):375-80.

The enlightenment of bladder cancer treatment: origin and progress of photodynamic diagnosis.
Otto W, Burger M, Fritsche HM, Rössler W, Wieland WF, Denzinger S.
Future Oncol. 2011 Sep;7(9):1057-66. Review.

Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.
Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G.
World J Urol. 2011 Aug;29(4):487-94.

Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.
Otto W, Fritsche HM, Wild PJ, Wieland WF, Hartmann A, Burger M, Hofstädter F, Denzinger S.
Pathol Res Pract. 2011 Mar 15;207(3):161-3.

The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer.
Otto W, Denzinger S, Fritsche HM, Burger M, Wieland WF, Hofstädter F, Hartmann A, Bertz S.
BJU Int. 2011 Feb;107(3):404-8.

Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?.
May M, Burger M, Brookman-May S, Otto W, Peter J, Rud O, Fritsche HM, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Bretschneider-Ehrenberg P, Müller O, Zacharias M, Gunia S, Bastian PJ.
Urologe A. 2011 Jun;50(6):706-13. German.

Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder.
May M, Fritsche HM, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Müller O, Bretschneider-Ehrenberg P, Zacharias M, Gunia S, Bastian PJ.
Urologe A. 2011 Jul;50(7):821-9. German.

Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma.
Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G.
World J Urol. 2011 Aug;29(4):481-6.

Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.
May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ.
Eur Urol. 2011 May;59(5):712-8.

Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.
May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ.
Ann Surg Oncol. 2011 Jul;18(7):2018-25.

DNA adducts of ortho-toluidine in human bladder.
Böhm F, Schmid D, Denzinger S, Wieland WF, Richter E.
Biomarkers. 2011 Mar;16(2):120-8.

Medical and Economic Aspects of Extracorporeal Shock Wave Lithotripsy.
Knoll T, Fritsche HM, Rassweiler J.
Aktuelle Urol. 2011 Nov;42(6):363-7.

Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
Nuhn P, Bastian PJ, Novara G, Svatek RS, Karakiewicz PI, Skinner E, Fradet Y, Izawa JI, Kassouf W, Montorsi F, Müller SC, Fritsche HM, Sonpavde G, Tilki D, Isbarn H, Ficarra V, Dinney CP, Shariat SF.
Urol Int. 2011;87(1):42-8.

No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.
Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A, Tritschler S, Walton TJ, Novara G.
World J Urol. 2011 Aug;29(4):465-72.

Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M, Shariat SF.
BJU Int. 2011 Oct;108(8 Pt 2):E304-9.

Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martínez-Salamanca JI, Scherr DS, Shariat SF.
World J Urol. 2011 Aug;29(4):473-80.

Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy.
Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Scherr DS, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF.
J Urol. 2011 Apr;185(4):1216-21

Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort.
Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, Kamat AM, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Dinney CP.
BJU Int. 2011 Mar;107(6):898-904.

Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer.
Sonpavde G, Khan MM, Lerner SP, Svatek RS, Novara G, Karakiewicz PI, Skinner E, Tilki D, Kassouf W, Fradet Y, Dinney CP, Fritsche HM, Izawa JI, Bastian PJ, Ficarra V, Schoenberg M, Sagalowsky AI, Lotan Y, Shariat SF.
J Urol. 2011 Feb;185(2):456-61.

Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF.
BJU Int. 2011 Sep;108(5):687-92.

Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.
Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF.
BJU Int. 2011 Aug;108(3):406-12.

The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma.
Keck B, Stoehr R, Wach S, Rogler A, Hofstaedter F, Lehmann J, Montironi R, Sibonye M, Fritsche HM, Lopez-Beltran A, Epstein JI, Wullich B, Hartmann A.
Int J Cancer. 2011 Jul 15;129(2):346-54.

2010

Association between residual urinary volume and urinary tract infection: prospective trial in 225 male patients.
Brookman-May S, Burger M, Hoschke B, Wieland WF, Kendel F, Gilfrich C, Braun KP, May M
Urologe A. 2010;49(9): 1163-8

Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?
Brookman-May S, May M, Gilfrich C, Wieland WF, Burger M
Expert Rev Anticancer Ther. 2010;10(6): 813-23

Urinary collecting system invasion reflects adverse long-term outcome and is associated with simultaneous metastatic spread at the time of surgery and with multilocular dissemination during postsurgical follow-up in renal cell cancer.
Brookman-Amissah S, May M, Albrecht K, Herrmann T, Roigas J, Gilfrich CP, Pflanz S, Gunia S.
World J Urol. 2010 Feb;28(1):103-9.

The application of adjuvant autologous intravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.
Burger M, Thiounn N, Denzinger S, Kondas J, Benoit G, Chapado MS, Jimenez-Cruz FJ, Kisbenedek L, Szabo Z, Zsolt D, Grimm MO, Romics I, Thuroff JW, Kiss T, Tombal B, Wirth M, Munsell M, Mills B, Koh T, Sherman J
J Transl Med. 2010;8(1): 54

Editorial comment on: prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications.
Burger M
Eur Urol. 2010;57(5): 858

Robot-assisted high-intensity focused ultrasound in focal therapy of prostate cancer.                  
Chaussy CG, Thüroff S
J Endourol. 2010;24(5):843-7.

High-intensity focused ultrasound in the management of prostate cancer.                                        
Chaussy CG, Thüroff S
Expert Rev Med Devices. 2010;7(2):209-17.

Legends in urology
Chaussy CG
Can J Urol. 2010;17(6):5425-7.

Long-term follow-up of male patients after reconstruction of the bladder-exstrophy-epispadias complex: psychosocial status, continence, renal and genital function.
Ebert AK, Schott G, Bals-Pratsch M, Seifert B, Rösch WH
J Pediatr Urol. 2010;6(1): 6-10

Pelvic-floor imaging using three-dimensional ultrasonography and magnetic resonance imaging in the long term follow-up of the bladder-exstrophy-epispadias complex.
Ebert AK, Falkert A, Brandl R, Hirschfelder H, Koller M, Rösch WH
BJU Int. 2010;105(2): 248-53

Characteristics and outcomes of patients with clinical t1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF
Eur Urol. 2010;57(2): 300-9

Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder.
Fritsche HM, Burger M, Dietmaier W, Denzinger S, Bach E, Otto W, Doblinger M, Schwarz S, Buchner H, Hartmann A
Am J Clin Pathol. 2010;134(4): 597-603

Do we have enough evidence to recommend the routine use of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer?
Ganzer R, Blana A
Eur Urol. 2010;58(6): 816-8

Neuroendocrine carcinoma of the seminal vesicles presenting with Lambert Eaton syndrome: a case report.
Kreiner B, Denzinger S, Ganzer R, Fritsche HM, Burger M, Wieland WF, Otto W
J Med Case Reports. 2010;4: 320

Analysis of Clinical, Histopathological and Follow-Up Data on Transurethral Resections of the Bladder Performed during One Year at a University Centre.
Otto W, Fritsche HM, Dirmeyer M, Burger M, Straub M, Rössler W, Wieland WF, Denzinger S
Aktuelle Urol. 2010;41(5): 316-9

Ongoing outbreak of mumps affecting adolescents and young adults inBavaria,Germany, August to October 2010.
Otto W, Mankertz A, Santibanez S, Saygili H, Wenzel J, Jilg W, Wieland W, Borgmann S
Euro Surveill. 2010;15(50)

Concordance of the Gleason score in prostate multibiopsy and definitive histology.
May M, Brookman-May S, Lebentrau S, Gilfrich C, Loy V, Theissig F, Roigas J, Hoschke B, Burger M, Miller K
Aktuelle Urol. 2010;41(3): 184-92

Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
Bolenz C, Herrmann E, Bastian PJ, Michel MS, Wülfing C, Tiemann A, Buchner A, Stief CG, Fritsche HM, Burger M, Wieland WF, Höfner T, Haferkamp A, Hohenfellner M, Müller SC, Ströbel P, Trojan L
BJU Int. 2010;106(4): 493-9

International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Novara G, Fritsche HM, Izawa JI, Ficarra V, Lerner SP, Sagalowsky AI, Schoenberg MP, Kamat AM, Dinney CP, Lotan Y, Marberger MJ, Fradet Y
BJU Int. 2010;105(10): 1402-12

Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
Zaak D, Burger M, Otto W, Bastian PJ, Denzinger S, Stief CG, Buchner H, Hartmann A, Wieland WF, Shariat SF, Fritsche HM
BJU Int. 2010;106(3): 342-8

Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores.
Ikenberg K, Fritzsche FR, Zuerrer-Haerdi U, Hofmann I, Hermanns T, Seifert H, Müntener M, Provenzano M, Sulser T, Behnke S, Gerhardt J, Mortezavi A, Wild P, Hofstädter F, Burger M, Moch H, Kristiansen G
BMC Cancer. 2010;10: 341

Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting.
May M, Brookman-May S, Hoschke B, Gilfrich C, Kendel F, Baxmann S, Wittke S, Kiessig ST, Miller K, Johannsen M.
Cancer Immunol Immunother. 2010 May;59(5):687-95.

Retroperitoneal bronchogenic cyst treated by laparoscopic surgery
Rud O, May M, Brookman-Amissah S, Moersler J, Greiner A, Gilfrich C.
Chirurg. 2010 Mar;81(3):243-6

The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder.
Svatek RS, Shariat SF, Lasky RE, Skinner EC, Novara G, Lerner SP, Fradet Y, Bastian PJ, Kassouf W, Karakiewicz PI, Fritsche HM, Muller SC, Izawa JI, Ficarra V, Sagalowsky AI, Schoenberg MP, Siefker-Radtke AO, Millikan RE, Dinney CP
Clin Cancer Res. 2010; 16(17): 4461-7

Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma.
Schlenker B, Seitz M, Bader MJ, Ganzer R, Tilki D, Bayrle F, Reich O, Staehler M, Bachmann A, Stief CG, Gratzke C
Eur J Med Res. 2010;15(6): 253-7

The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression.
Catto JW, Abbod MF, Wild PJ, Linkens DA, Pilarsky C, Rehman I, Rosario DJ, Denzinger S, Burger M, Stoehr R, Knuechel R, Hartmann A, Hamdy FC
Eur Urol. 2010;57(3): 398-406

Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications.
May M, Brookman-Amissah S, Roigas J, Hartmann A, Störkel S, Kristiansen G, Gilfrich C, Borchardt R, Hoschke B, Kaufmann O, Gunia S.
Eur Urol. 2010;57(5):850-8.

Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer.
Engel J, Bastian PJ, Baur H, Beer V, Chaussy CG, Gschwend JE, Oberneder R, Rothenberger KH, Stief CG, Hölzel D.   
Eur Urol. 2010;57(5):754-61.

Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study.
Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martínez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF
Eur Urol. 2010;57(6): 1064-71

Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation.
Schatz P, Dietrich D, Koenig T, Burger M, Lukas A, Fuhrmann I, Kristiansen G, Stoehr R, Schuster M, Lesche R, Weiss G, Corman J, Hartmann A
J Mol Diagn. 2010;12(3): 345-53

Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.
Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A
J Urol. 2010;183(2): 460-6

Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.
Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Otto W, Tritschler S, Bastian PJ, Carballido J, Ficarra V, Karakiewicz PI, Artibani W, Mazzoleni G, Novara G
J Urol. 2010;184(5): 1895-900

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.
Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB
J Urol. 2010;184(5): 1907-13

Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF
J Urol. 2010;183(5): 1757-63 

Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients.
Tilki D, Svatek RS, Karakiewicz PI, Isbarn H, Reich O, Kassouf W, Fradet Y, Novara G, Fritsche HM, Bastian PJ, Izawa JI, Stief CG, Ficarra V, Lerner SP, Schoenberg M, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF
J Urol. 2010;183(1): 87-93

Mutational activation of FGFR3 is not involved in the development of prostate cancer.
Koufou S, Lunz JC, Borchardt A, Keck B, Kneitz B, Gaisa NT, Hafner C, Giedl C, Rau TT, Rogler A, Wieland WF, Hartmann A, Stoehr R
Pathobiology. 2010;77(5): 249-52

Patients with bladder cancer in clinical stage T2: survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens.
May M, Fritsche HM, Brookman-May S, Burger M, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Bastian PJ
Urologe A. 2010;49(12): 1508-15

Abscess-forming retroperitoneal actinomycosis after urogynaecological surgery
Rud O, May M, Brookman-May S, Mörsler J, Rotter M, Gilfrich C.
Urologe A. 2010 Oct;49(10):1283-6

A comparison of outcomes for interfascial and intrafascial nerve-sparing radical prostatectomy.
Stolzenburg JU, Kallidonis P, Do M, Dietel A, Häfner T, Rabenalt R, Sakellaropoulos G, Ganzer R, Paasch U, Horn LC, Liatsikos E
Urology. 2010;76(3): 743-8

Evaluation of renocapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.
May M, Brookman-Amissah S, Roigas J, Gilfrich CP, Pflanz S, Hoschke B, Gunia S.
Urol Oncol. 2010 May-Jun;28(3):274-9.

Modular therapy approach in metastatic castration-refractory prostate cancer.
Walter B, Rogenhofer S, Vogelhuber M, Berand A, Wieland WF, Andreesen R, Reichle A
World J Urol. 2010;28(6): 745-50

2009

High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
Blana A, Brown SC, Chaussy C, Conti GN, Eastham JA, Ganzer R, Murat FJ, Pasticier G, Rebillard X, Rewcastle JC, Robertson CN, Thuroff S, Ward JF.
BJU Int. 2009 Oct;104(8):1058-62. Epub 2009 Apr 17.
PMID: 19388986

Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
Burger M.
Eur Urol. 2008 Dec;54(6):1236. Epub 2008 Aug 12. No abstract available.
PMID: 18715704

Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Burger M, Stief CG, Zaak D, Stenzl A, Wieland WF, Jocham D, Otto W, Denzinger S.
Urology. 2009 Dec;74(6):1282-6. Epub 2009 Oct 12.
PMID: 19819538

Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Burger M, Stief CG, Zaak D, Stenzl A, Wieland WF, Jocham D, Otto W, Denzinger S.
Urology. 2009 Dec;74(6):1282-6. Epub 2009 Oct 12.
PMID: 19819538

Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder.
Denzinger S, Burger M, Fritsche HM, Bertz S, Hofstädter F, Wieland WF, Hartmann A, Otto W.
Scand J Urol Nephrol. 2009;43(4):282-7.
PMID: 19382004

Characteristics and outcomes of patients with clinical t1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF.
Eur Urol. 2010 Feb;57(2):300-9. Epub 2009 Sep 12.
PMID: 19766384

Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease.
Fritsche HM, Ganzer R, Schlaier J, Wieland WF, Brawanski A, Lange M.
Mov Disord. 2009 Jul 30;24(10):1553-4. No abstract available.
PMID: 19441136

Nerve quantification and computerized planimetry to evaluate periprostatic nerve distribution-does size matter?
Ganzer R, Blana A, Stolzenburg JU, Rabenalt R, Fritsche HM, Wieland WF, Denzinger S.
Urology. 2009 Aug;74(2):398-403. Epub 2009 Apr 18.
PMID: 19375785

Anatomical description of the periprostatic nerves in the male rhesus monkey (Macaca mulatta).
Ganzer R, Neuhaus J, Gratzke C, Blana A, Wieland WF, Stolzenburg JU.
World J Urol. 2009 Sep 16. [Epub ahead of print]
PMID: 19760222

Intraoperative photodynamic evaluation of surgical margins during endoscopic extraperitoneal radical prostatectomy with the use of 5-aminolevulinic acid.
Ganzer R, Blana A, Denzinger S, Wieland WF, Adam C, Becker A, Khoder W, Walther S, Stief CG, Zaak D, Salomon G, Hartmann A, Knuechel R, Bertz S, Popken G.
J Endourol. 2009 Sep;23(9):1387-94.
PMID: 19673655

Does technical progress mean clinical advantage? Analysis of clinical and histopathological parameters of renal cell carcinomas in long-term course]
Otto W, Hübner I, Burger M, Rössler W, Wieland WF, Denzinger S.
Aktuelle Urol. 2009 Sep;40(5):303-6. Epub 2009 Aug 7. German.
PMID: 19670107

No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer.
Otto W, Denzinger S, Bertz S, Gaumann A, Wild PJ, Hartmann A, Stoehr R.
Int J Cancer. 2009 Nov 1;125(9):2205-8.
PMID: 19621447

Long-term follow-up of male patients after reconstruction of the bladder-exstrophy-epispadias complex: psychosocial status, continence, renal and genital function.
Ebert AK, Schott G, Bals-Pratsch M, Seifert B, Rösch WH.
J Pediatr Urol. 2010 Feb;6(1):6-10. Epub 2009 Jul 10.
PMID: 19596609

Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
Zaak D, Burger M, Otto W, Bastian PJ, Denzinger S, Stief CG, Buchner H, Hartmann A, Wieland WF, Shariat SF, Fritsche HM.
BJU Int. .
PMID: 20002664

Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis.
Wild PJ, Fuchs T, Stoehr R, Zimmermann D, Frigerio S, Padberg B, Steiner I, Zwarthoff EC, Burger M, Denzinger S, Hofstaedter F, Kristiansen G, Hermanns T, Seifert HH, Provenzano M, Sulser T, Roth V, Buhmann JM, Moch H, Hartmann A.
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1798-806. Epub 2009 May 19.
PMID: 19454613

Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure.
Adam C, Salomon G, Walther S, Zaak D, Khoder W, Becker A, Reich O, Blana A, Ganzer R, Denzinger S, Popken G, Sroka R, Knüchel-Clarke R, Köllermann J, Sauter G, Hartmann A, Bertz S, Graefen M, Huland H, Wieland W, Stief CG.
Eur Urol. 2009 Jun;55(6):1281-8. Epub 2009 Mar 3.
PMID: 19328622

The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression.
Catto JW, Abbod MF, Wild PJ, Linkens DA, Pilarsky C, Rehman I, Rosario DJ, Denzinger S, Burger M, Stoehr R, Knuechel R, Hartmann A, Hamdy FC.
Eur Urol. 2010 Mar;57(3):398-406. Epub 2009 Nov 6.
PMID: 19913990

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.
van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, Witjes JA, Zlotta AR.
Eur Urol. 2009 Sep;56(3):430-42. Epub 2009 Jun 26. Review.
PMID: 19576682

Sleep apnea is an independent correlate of erectile and sexual dysfunction.
Budweiser S, Enderlein S, Jörres RA, Hitzl AP, Wieland WF, Pfeifer M, Arzt M.
J Sex Med. 2009 Nov;6(11):3147-57. Epub 2009 Jun 29.
PMID: 19570042

Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.
Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A.
J Urol. 2010 Feb;183(2):460-6. Epub 2009 Dec 14.

Novel electromagnetic lithotriptor for upper tract stones with and without a ureteral stent.
Seitz C, Fritsche HM, Siebert T, Martini T, Wieland WF, Pycha A, Burger M.
J Urol. 2009 Oct;182(4):1424-9. Epub 2009 Aug
15.PMID: 19683296

Thulium:YAG vaporesection of the prostate. First results]
Bach T, Herrmann TR, Ganzer R, Blana A, Burchardt M, Gross AJ.
Urologe A. 2009 May;48(5):529-34. German.
PMID: 19183928

Peripheral primitive neuroectodermal tumor of the urinary bladder in an Arab woman with history of squamous cell carcinoma: a case report.
Al Meshaan MK, Nayef M, Kwaider T, Otto W, Katchy KC.
J Med Case Reports. 2009 Apr 29;3:6840.
PMID: 19830128

Value of frozen section biopsies during radical prostatectomy: significance of the histological results.
Ramírez-Backhaus M, Rabenalt R, Jain S, Do M, Liatsikos E, Ganzer R, Horn LC, Burchardt M, Jiménez-Cruz F, Stolzenburg JU.
World J Urol. 2009 Apr;27(2):227-34. Epub 2008 Dec 10. Review.
PMID: 19082603

Late diagnosis of cryptorchidism
Körner I, Neissner C, Steckermeier J, Rösch WH.
Urologe A. 2009 Sep;48(9):1032-4, 1036-7. German.
PMID: 19697004

The exstrophy-epispadias complex.
Ebert AK, Reutter H, Ludwig M, Rösch WH.
Orphanet J Rare Dis. 2009 Oct 30;4:23. Review.
PMID: 19878548

Long-term follow-up of male patients after reconstruction of the bladder-exstrophy-epispadias complex: psychosocial status, continence, renal and genital function.
Ebert AK, Schott G, Bals-Pratsch M, Seifert B, Rösch WH.
J Pediatr Urol. 2010 Feb;6(1):6-10. Epub 2009 Jul 10.
PMID: 19596609

2008

Denzinger S, Wieland WF, Otto W.
Modern diagnosis of bladder cancer
MMW Fortschr Med. 2008 Jan 31;150(5):36-9; quiz 41. Review. German. No abstract available.
PMID: 18300553

Denzinger S, Burger M, Fritsche HM, Ganzer R, Blana A, Wieland WF, Otto W.
Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?
Aktuelle Urol. 2008 Jan;39(1):58-61; discussion 62-3. German.
PMID: 18228189

Denzinger S, Fritsche HM, Otto W, Blana A, Wieland WF, Burger M.
Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
Eur Urol. 2008 Jan;53(1):146-52. Epub 2007 Jun 27.
PMID: 17624657

Denzinger S, Wieland WF, Otto W, Filbeck T, Knuechel R, Burger M.
Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
BJU Int. 2008 Mar;101(5):566-9. Epub 2007 Nov 5.
PMID: 17986289

Karl A, Zaak D, Tilki D, Hungerhuber E, Staehler M, Denzinger S, Stanislaus P, Tritschler S, Strittmatter F, Stief C, Burger M.
Diagnosis of urothelial carcinoma
Urologe A. 2008 Mar;47(3):357-67. German.
PMID: 18274722

Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, Blana A.
PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
Eur Urol. 2008 Mar;53(3):547-53. Epub 2007 Jul 17.
PMID: 17662520

Denzinger S, Burger M.
Photodynamic diagnostics of bladder tumors.
Curr Urol Rep. 2008 Mar;9(2):101-5. Review.
PMID: 18419993 [PubMed - indexed for MEDLINE]

Blana A, Hierl J, Rogenhofer S, Lunz JC, Wieland WF, Walter B, Bach T, Ganzer R.
Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.
Urology. 2008 May;71(5):863-7. Epub 2008 Mar 3.
PMID: 18313119

Fritsche HM, Burger M, Ganzer R, Otto W, Denzinger S, Wieland WF.
[Impact of comorbidity on perioperative mortality after radical cystectomy]
Aktuelle Urol. 2008 May;39(3):225-8. German.
PMID: 18478497

Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C, Gelet A.
First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.
Eur Urol. 2008 Jun;53(6):1194-201. Epub 2007 Nov 5.
PMID: 17997026

Stoehr R, Hitzenbichler F, Kneitz B, Hammerschmied CG, Burger M, Tannapfel A, Hartmann A.
Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics.
Br J Cancer. 2008 Jul 8;99(1):78-82. Epub 2008 Jun 24.
PMID: 18577987

Burger M, Denzinger S, Wieland WF, Stief CG, Hartmann A, Zaak D.
Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset?
BJU Int. 2008 Jul;102(2):194-7. Epub 2008 Jul 1.
PMID: 18435811

Ganzer R, Rabenalt R, Truss MC, Papadoukakis S, Do M, Blana A, Straub M, Denzinger S, Wieland WF, Burchardt M, Herrmann T, Stolzenburg JU.
Evaluation of complications in endoscopic extraperitoneal radical prostatectomy in a modular training programme: a multicentre experience.
World J Urol. 2008 Jul 16. [Epub ahead of print]
PMID: 18629505

Ganzer R, Blana A, Gaumann A, Stolzenburg JU, Rabenalt R, Bach T, Wieland WF, Denzinger S.
Topographical anatomy of periprostatic and capsular nerves: quantification and computerised planimetry.
Eur Urol. 2008 Aug;54(2):353-61. Epub 2008 Apr 15.
PMID: 18436370

Denzinger S, Burger M, Hammerschmied CG, Wieland WF, Hartmann A, Obermann EC, Stoehr R.
Pax-5 protein expression in bladder cancer: a preliminary study that shows no correlation to grade, stage or clinical outcome.
Pathology. 2008 Aug;40(5):465-9.
PMID: 18604731

Retz M, Hartmann A, Merseburger A, Olbert P, Stoehr R, Nawroth R.
[German Association for Bladder Cancer Research]
Urologe A. 2008 Sep;47(9):1141-2, 1144. German.
PMID: 18696040

Blana A, Rogenhofer S, Ganzer R, Lunz JC, Schostak M, Wieland WF, Walter B.
Eight Years' Experience With High-Intensity Focused Ultrasonography for Treatment of Localized Prostate Cancer.
Urology. 2008 Sep 29. [Epub ahead of print]
PMID: 18829078 [PubMed - as supplied by publisher]

Ganzer R, Wieland WF, Stolzenburg JU.
Reply to Declan G. Murphy, Ben Dowdle and Anthony J Costello's Letter to the Editor re: Roman Ganzer, Andreas Blana, Andreas Gaumann, et al. Topographical Anatomy of Periprostatic and Capsular Nerves: Quantification and Computerised Planimetry. Eur Urol 2008;54:353-61.
Eur Urol. 2008 Oct 9. [Epub ahead of print] No abstract available.
PMID: 18922620

Burger M, van der Aa MN, van Oers JM, Brinkmann A, van der Kwast TH, Steyerberg EC, Stoehr R, Kirkels WJ, Denzinger S, Wild PJ, Wieland WF, Hofstaedter F, Hartmann A, Zwarthoff EC.
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.
Eur Urol. 2008 Oct;54(4):835-43. Epub 2007 Dec 26.
PMID: 18166262

Eltze E, Wild PJ, Wülfing C, Zwarthoff EC, Burger M, Stoehr R, Korsching E, Hartmann A.
Expression of the Endothelin Axis in Noninvasive and Superficially Invasive Bladder Cancer: Relation to Clinicopathologic and Molecular Prognostic Parameters.
Eur Urol. 2008 Oct 11. [Epub ahead of print]
PMID: 18945538

Fritsche HM, Burger M, Denzinger S, Legal W, Goebell PJ, Hartmann A.
Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
J Urol. 2008 Nov;180(5):1923-7. Epub 2008 Sep 17.
PMID: 18801525

Gaumann A, Bode-Lesniewska B, Zimmermann DR, Fanburg-Smith JC, Kirkpatrick CJ, Hofstädter F, Woenckhaus M, Stoehr R, Obermann EC, Dietmaier W, Hartmann A.
Exploration of the APC/beta-catenin (WNT) pathway and a histologic classification system for pulmonary artery intimal sarcoma. A study of 18 cases.
Virchows Arch. 2008 Nov;453(5):473-84. Epub 2008 Sep 20.
PMID: 18807072

Fritsche HM, Burger M.
Management of early-invasive high-grade transitional cell carcinoma of the bladder.
Minerva Urol Nefrol. 2008 Dec;60(4):265-71.
PMID: 18923363

2007

Wild PJ, Catto JW, Abbod MF, Linkens DA, Herr A, Pilarsky C, Wissmann C, Stoehr R, Denzinger S, Knuechel R, Hamdy FC, Hartmann A.
Artificial intelligence and bladder cancer arrays.
Verh Dtsch Ges Pathol. 2007;91:308-19.
PMID: 18314629

Denzinger S, Ganzer R, Fink A, Wieland WF, Blana A.
Open partial nephrectomy for imperative and elective indications comparison of peri-operative data and long-term follow-up.
Scand J Urol Nephrol. 2007;41(6):496-500.
PMID: 17853016

Hammerschmied CG, Stoehr R, Walter B, Wieland WF, Hartmann A, Blaszyk H, Denzinger S.
Role of the STK15 Phe31Ile polymorphism in renal cell carcinoma.
Oncol Rep. 2007 Jan;17(1):3-7.
PMID: 17143471

Ganzer R, Wieland WF, Bach T, Rössler W, Blana A.
Hormonal treatment of cancer of the prostate: review and present status
Dtsch Med Wochenschr. 2007 Jan 26;132(4):161-6. Review. German. No abstract available.
PMID: 17230333

Denzinger S, Otto W, Burger M, Hammerschmied C, Junker K, Hartmann A, Wieland WF, Walter B.
Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
World J Surg Oncol. 2007 Feb 5;5:16.
PMID: 17280613

Denzinger S, Burger M, Hartmann A, Hofstaedter F, Wieland WF, Ganzer R.
Spontaneous rupture of a benign giant adrenal adenoma.
APMIS. 2007 Apr;115(4):381-4.
PMID: 17504308

Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, Filbeck T.
Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
Urology. 2007 Apr;69(4):675-9.
PMID: 17445650

Denzinger S, Luebke L, Burger M, Kessler S, Wieland WF, Otto W.
Vacuum-assisted closure therapy in ureteroileal anastomotic leakage after surgical therapy of bladder cancer.
World J Surg Oncol. 2007 Apr 12;5:41.
PMID: 17430598

Denzinger S, Lübke L, Roessler W, Wieland WF, Kessler S, Burger M.
Vacuum-assisted closure versus conventional wound care in the treatment of wound failures following inguinal lymphadenectomy for penile cancer: a retrospective study.
Eur Urol. 2007 May;51(5):1320-5. Epub 2006 Dec 22.
PMID: 17207916

Blana A, Denzinger S, Lenhart M, Wieland WF, Ganzer R.
Treatment of a recurrent inguinal lymphocele in a penis cancer patient by lymphography and selective ligation of lymphatic vessels.
Int J Urol. 2007 May;14(5):450-1.
PMID: 17511733

Denzinger S, Watzlawek E, Burger M, Wieland WF, Otto W.
Giant scrotal elephantiasis of inflammatory etiology: a case report.
J Med Case Reports. 2007 Jun 2;1(1):23.
PMID: 17543128

Burger M, Denzinger S, Hartmann A, Wieland WF, Stoehr R, Obermann EC.
Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade.
Br J Cancer. 2007 Jun 4;96(11):1711-5. Epub 2007 May 15.
PMID: 17505513

Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ.
RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up.
World J Urol. 2007 Jun;25(3):257-62. Epub 2007 May 25.
PMID: 17530258

Burger M, Junker K, Denzinger S, Schubert T, Stoehr R, Wieland WF, Hartmann A.
Metanephric adenoma of the kidney: a clinicopathological and molecular study of two cases.
J Clin Pathol. 2007 Jul;60(7):832-3. Epub 2006 Nov 10. No abstract available.
PMID: 17098885

Burger M, Zaak D, Stief CG, Filbeck T, Wieland WF, Roessler W, Denzinger S.
Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis.
Eur Urol. 2007 Jul;52(1):142-7. Epub 2007 Jan 22.
PMID: 17267099

Burger M, Zaak D, Stief CG, Filbeck T, Wieland WF, Roessler W, Denzinger S.
Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis.
Eur Urol. 2007 Jul;52(1):142-7. Epub 2007 Jan 22.
PMID: 17267099

Burger M, Junker K, Denzinger S, Schubert T, Stoehr R, Wieland WF, Hartmann A.
Metanephric adenoma of the kidney: a clinicopathological and molecular study of two cases.
J Clin Pathol. 2007 Jul;60(7):832-3. Epub 2006 Nov 10. No abstract available.
PMID: 17098885

Blana A, Straub M, Wild PJ, Lunz JC, Bach T, Wieland WF, Ganzer R.
Approach to endoscopic extraperitoneal radical prostatectomy (EERPE): the impact of previous laparoscopic experience on the learning curve.
BMC Urol. 2007 Jul 9;7:11.
PMID: 17617927

Ganzer R, Burger M, Woenckhaus M, Wieland WF, Blana A.
A patient with testicular pseudolymphoma - a rare condition mimicking malignancy: a case report.
J Med Case Reports. 2007 Aug 25;1(1):71.
PMID: 17718926

Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knüchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG.
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Oncogene. 2007 Aug 16;26(38):5680-91. Epub 2007 Mar 12.
PMID: 17353908

van Oers JM, Wild PJ, Burger M, Denzinger S, Stoehr R, Rosskopf E, Hofstaedter F, Steyerberg EW, Klinkhammer-Schalke M, Zwarthoff EC, van der Kwast TH, Hartmann A.
FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.
Eur Urol. 2007 Sep;52(3):760-8. Epub 2007 Jan 12.
PMID: 17240035

Denzinger S, Wieland WF, Burger M, Otto W.
Spontaneous ventral urethral fistula in a young diabetic man: a case report.
J Med Case Reports. 2007 Sep 5;1:80.
PMID: 17803821

Denzinger S, Hartmann A, Hofstaedter F, Knuechel R, Wild PJ, Zaak D, Stief C, Wieland WF, Stoehr R, Burger M.
[Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder]
Urologe A. 2007 Sep;46(9):1126-8. German. No abstract available.
PMID: 17634910

Burger M, Hartmann A, Stoehr R, Hofstaedter F, Kneitz B, Riedmiller H, Wieland WF, Denzinger S.
Organization of data and tissue banks for new prognostic factors in adenocarcinoma of the prostate. An interdisciplinary uropathologic approach
Urologe A. 2007 Sep;46(9):1094. German. No abstract available.
PMID: 17628773

Burger M, Hartmann A, Stoehr R, Hofstaedter F, Kneitz B, Riedmiller H, Wieland WF, Denzinger S.
Organization of data and tissue banks for new prognostic factors in adenocarcinoma of the prostate. An interdisciplinary uropathologic approach
Urologe A. 2007 Sep;46(9):1094. German. No abstract available.
PMID: 17628773

Denzinger S, Stoehr R, Schwarz S, Eichenseher N, Brockhoff G, Obermann EC, Knuechel R, Blaszyk H, Hartmann A, Wild PJ.
Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.
Int J Oncol. 2007 Oct;31(4):793-802.
PMID: 17786310

Schostak M, Braun C, Krause H, Miller K, Kempkensteffen C, Hinz S, Strenziok R, Blana A, Schrader M.
New polymorphisms in the PSA promoter in patients with prostate carcinoma
Aktuelle Urol. 2007 Nov;38(6):465-72. German.
PMID: 17987534

Denzinger S, Rössler W, Otto W.
Photodynamic diagnostic of superficial bladder carcinoma
Dtsch Med Wochenschr. 2007 Nov;132(44):2332-5. German.
PMID: 17957598

Denzinger S, Otto W, Fritsche HM, Roessler W, Wieland WF, Hartmann A, Burger M.
Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients.
Int J Urol. 2007 Nov;14(11):995-9; discussion 999.
PMID: 17956523

Zaak D, Karl A, Stepp H, Tritschler S, Tilki D, Burger M, Knuechel R, Stief C.
Fluorescence cystoscopy at bladder cancer: present trials
Urologe A. 2007 Nov;46(11):1519-27. Review. German.
PMID: 17928985

Burger M.
Editorial comment on: Long-term tolerability of tolterodine extended release in children 5-11 years of age: results from a 12-month, open-label study.
Eur Urol. 2007 Nov;52(5):1516-7. No abstract available.
PMID: 17574732

2006

Denzinger S, Mohren K, Knuechel R, Wild PJ, Burger M, Wieland WF, Hartmann A, Stoehr R.
Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Hum Pathol. 2006 Feb;37(2):143-51. Epub 2005 Dec 15.
PMID: 16426913

Stolzenburg JU, Neuhaus J, Liatsikos EN, Schwalenberg T, Ludewig E, Ganzer R.
Histomorphology of canine urethral sphincter systems, including three-dimensional reconstruction and magnetic resonance imaging.
Urology. 2006 Mar;67(3):624-30.
PMID: 16527594

van Oers JM, Adam C, Denzinger S, Stoehr R, Bertz S, Zaak D, Stief C, Hofstaedter F, Zwarthoff EC, van der Kwast TH, Knuechel R, Hartmann A.
Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder.
Int J Cancer. 2006 Sep 1;119(5):1212-5.
PMID: 16570285

Ibach B, Binder H, Dragon M, Poljansky S, Haen E, Schmitz E, Koch H, Putzhammer A, Kluenemann H, Wieland W, Hajak G.
Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample.
Neurobiol Aging. 2006 Sep;27(9):1202-11. Epub 2005 Aug 8.
PMID: 16085339

Schnitzbauer AA, Loss M, Hornung M, Farkas S, Krämer B, Wieland W, Schlitt HJ, Obed A.
[Pararectal mini-incision for strictly retroperitoneal nephrectomy in living kidney donation]
Urologe A. 2006 Sep;45(9):1170-5. German.
PMID: 16767454

Burger M, Denzinger S, Hammerschmied CG, Tannapfel A, Obermann EC, Wieland WF, Hartmann A, Stoehr R.
Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.
J Mol Med. 2006 Oct;84(10):833-41. Epub 2006 Aug 3.
PMID: 16924473

Burger M, Burger SJ, Denzinger S, Wild PJ, Wieland WF, Blaszyk H, Obermann EC, Stoehr R, Hartmann A.
Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancer.
Eur Urol. 2006 Oct;50(4):770-5; discussion 776. Epub 2006 May 2.
PMID: 16762487

Wagenlehner FM, Lunz JC, Kees F, Wieland W, Naber KG.
Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
J Chemother. 2006 Oct;18(5):485-9.
PMID: 17127224

Burger M, Denzinger S, Hammerschmied C, Tannapfel A, Maderstorfer A, Wieland WF, Hartmann A, Stoehr R.
Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations.
Eur Urol. 2006 Nov;50(5):1102-9; discussion 1109-10. Epub 2006 Jan 6.
PMID: 16413100

Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WF, Walter B.
Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer.
World J Urol. 2006 Nov;24(5):585-90. Epub 2006 Jul 19.
PMID: 16850340

2005

Stoehr R, Zietz S, Burger M, Filbeck T, Denzinger S, Obermann EC, Hammerschmied C, Wieland WF, Knuechel R, Hartmann A.
Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
Eur Urol. 2005 Jan;47(1):58-63.
PMID: 15582250

Andreou C, Blana A, Orovan W, Hassouna M, Warner J, Woods E.
Technical review: High-intensity focused ultrasound for prostate cancer.
Can J Urol. 2005 Jun;12(3):2684-5; discussion 2686. No abstract available.
PMID: 16011815

Burger M, Denzinger S, Filbeck T, Hartmann A, Rössler W, Hammerschmied C.
A metachronous, atypical, multifocal renal oncocytoma with a concomitant renal cell carcinoma of the contralateral side and bilateral multifocal oncocytomas: two case reports and review of literature.
ScientificWorldJournal. 2005 Jul 20;5:545-9. Review.
PMID: 16075151

Wild PJ, Kunz-Schughart LA, Stoehr R, Burger M, Blaszyk H, Simon R, Gasser T, Mihatsch M, Sauter G, Hartmann A.
High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer.
Int J Oncol. 2005 Aug;27(2):385-91.
PMID: 16010419

Wild PJ, Kunz-Schughart LA, Stoehr R, Burger M, Blaszyk H, Simon R, Gasser T, Mihatsch M, Sauter G, Hartmann A.
High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer.
Int J Oncol. 2005 Aug;27(2):385-91.
PMID: 16010419